{"version":3,"file":"static/js/937.6d6519b1.chunk.js","mappings":"8MASO,MAAMA,EAA0B,CACrCC,MAAO,CAEL,CACEC,GAAI,QACJC,KAAM,mBACNC,KAAM,aACNC,KAAM,GACNC,YAAa,iLACbC,QAAS,oBACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,sDAEd,CACE,KAAQ,mBACR,SAAY,iDAEd,CACE,KAAQ,qBACR,SAAY,yDAEd,CACE,KAAQ,cACR,SAAY,wCAGdC,WAAY,kFAEd,CACEP,GAAI,SACJC,KAAM,eACNC,KAAM,aACNC,KAAM,GACNC,YAAa,mMACbC,QAAS,qBACTC,aAAc,CACd,CACE,KAAQ,iBACR,SAAY,wDAEd,CACE,KAAQ,uBACR,SAAY,wCAEd,CACE,KAAQ,kBACR,SAAY,2DAGdC,WAAY,yGAEd,CACEP,GAAI,YACJC,KAAM,MACNC,KAAM,aACNC,KAAM,GACNC,YAAa,4KACbC,QAAS,kBACTC,aAAc,CACd,CACE,KAAQ,0BACR,SAAY,mEAGdC,WAAY,sEAEd,CACEP,GAAI,MACJC,KAAM,MACNC,KAAM,aACNC,KAAM,GACNC,YAAa,6KACbC,QAAS,kBACTC,aAAc,CACd,CACE,KAAQ,mBACR,SAAY,8CAGdC,WAAY,qDAEd,CACEP,GAAI,MACJC,KAAM,MACNC,KAAM,aACNC,KAAM,GACNC,YAAa,mIACbC,QAAS,sBACTC,aAAc,CACd,CACE,KAAQ,iBACR,SAAY,+CAGdC,WAAY,4EAGd,CACEP,GAAI,MACJC,KAAM,MACNC,KAAM,aACNC,KAAM,GACNC,YAAa,uJACbC,QAAS,kBACTC,aAAc,CACd,CACE,KAAQ,qBACR,SAAY,qDAGdC,WAAY,gHAEd,CACEP,GAAI,OACJC,KAAM,OACNC,KAAM,gBACNC,KAAM,GACNC,YAAa,kSACbC,QAAS,wBACTC,aAAc,GACdC,WAAY,mGAEd,CACEP,GAAI,mBACJC,KAAM,mBACNC,KAAM,gBACNC,KAAM,GACNC,YAAa,6OACbC,QAAS,mCACTC,aAAc,GACdC,WAAY,gHAEd,CACEP,GAAI,WACJC,KAAM,yBACNC,KAAM,gBACNC,KAAM,GACNC,YAAa,+LACbC,QAAS,2BACTC,aAAc,GACdC,WAAY,mHAEd,CACEP,GAAI,QACJC,KAAM,QACNC,KAAM,gBACNC,KAAM,GACNC,YAAa,oKACbC,QAAS,8BACTC,aAAc,GACdC,WAAY,mIAEd,CACEP,GAAI,oBACJC,KAAM,oBACNC,KAAM,gBACNC,KAAM,GACNC,YAAa,oLACbC,QAAS,kCACTC,aAAc,GACdC,WAAY,mHAEd,CACEP,GAAI,qBACJC,KAAM,qBACNC,KAAM,gBACNC,KAAM,GACNC,YAAa,iMACbC,QAAS,0BACTC,aAAc,GACdC,WAAY,wKAEd,CACEP,GAAI,sBACJC,KAAM,sBACNC,KAAM,gBACNC,KAAM,GACNC,YAAa,uLACbC,QAAS,2BACTC,aAAc,GACdC,WAAY,uFAKd,CACEP,GAAI,SACJC,KAAM,cACNC,KAAM,iBACNC,KAAM,GACNC,YAAa,+IACbC,QAAS,qBACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,sDAGdC,WAAY,wEAEd,CACEP,GAAI,SACJC,KAAM,oBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,4HACbC,QAAS,+BACTC,aAAc,CACd,CACE,KAAQ,eACR,SAAY,sDAGdC,WAAY,mGAEd,CACEP,GAAI,SACJC,KAAM,SACNC,KAAM,UACNC,KAAM,GACNC,YAAa,2FACbC,QAAS,wBACTC,aAAc,CACd,CACE,KAAQ,qBACR,SAAY,yDAGdC,WAAY,qFAMd,CACEP,GAAI,WACJC,KAAM,WACNC,KAAM,UACNC,KAAM,GACNC,YAAa,+RACbC,QAAS,uBACTC,aAAc,CACd,CACE,KAAQ,cACR,SAAY,+CAGdC,WAAY,iLAEd,CACEP,GAAI,WACJC,KAAM,sBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,8IACbC,QAAS,yBACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,gDAGdC,WAAY,yEAEd,CACEP,GAAI,YACJC,KAAM,uBACNC,KAAM,iBACNC,KAAM,GACNC,YAAa,iKACbC,QAAS,2BACTC,aAAc,CACd,CACE,KAAQ,sBACR,SAAY,yDAGdC,WAAY,oFAEd,CACEP,GAAI,OACJC,KAAM,eACNC,KAAM,UACNC,KAAM,GACNC,YAAa,mHACbC,QAAS,2BACTC,aAAc,CACd,CACE,KAAQ,iBACR,SAAY,4CAGdC,WAAY,0GAEd,CACEP,GAAI,WACJC,KAAM,WACNC,KAAM,iBACNC,KAAM,GACNC,YAAa,gFACbC,QAAS,uBACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,sDAGdC,WAAY,kEAEd,CACEP,GAAI,iBACJC,KAAM,iBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,yLACbC,QAAS,4BACTC,aAAc,CACd,CACE,KAAQ,gBACR,SAAY,8CAEd,CACE,KAAQ,oBACR,SAAY,iDAEd,CACE,KAAQ,kBACR,SAAY,gDAEd,CACE,KAAQ,YACR,SAAY,kDAGdC,WAAY,+LAId,CACEP,GAAI,SACJC,KAAM,qBACNC,KAAM,KACNC,KAAM,GACNC,YAAa,4HACbC,QAAS,gCACTC,aAAc,CACd,CACE,KAAQ,YACR,SAAY,2CAEd,CACE,KAAQ,oBACR,SAAY,mDAGdC,WAAY,mHAEd,CACEP,GAAI,WACJC,KAAM,uBACNC,KAAM,KACNC,KAAM,GACNC,YAAa,4HACbC,QAAS,gCACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,0CAEd,CACE,KAAQ,eACR,SAAY,6CAEd,CACE,KAAQ,gBACR,SAAY,iDAGdC,WAAY,4GAEd,CACEP,GAAI,MACJC,KAAM,eACNC,KAAM,KACNC,KAAM,GACNC,YAAa,6IACbC,QAAS,yBACTC,aAAc,CACd,CACE,KAAQ,eACR,SAAY,6CAEd,CACE,KAAQ,eACR,SAAY,6CAGdC,WAAY,sGAGd,CACEP,GAAI,WACJC,KAAM,mBACNC,KAAM,KACNC,KAAM,GACNC,YAAa,kHACbC,QAAS,gCACTC,aAAc,CACd,CACE,KAAQ,kBACR,SAAY,yDAGdC,WAAY,iGAGd,CACEP,GAAI,qBACJC,KAAM,4BACNC,KAAM,KACNC,KAAM,GACNC,YAAa,iPACbC,QAAS,sCACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,2CAGdC,WAAY,wHAOd,CACEP,GAAI,OACJC,KAAM,OACNC,KAAM,YACNC,KAAM,GACNC,YAAa,0IACbC,QAAS,mBACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,4CAGdC,WAAY,mFAEd,CACEP,GAAI,WACJC,KAAM,WACNC,KAAM,YACNC,KAAM,GACNC,YAAa,uIACbC,QAAS,8BACTC,aAAc,CACd,CACE,KAAQ,uBACR,SAAY,yCAGdC,WAAY,+DAEd,CACEP,GAAI,YACJC,KAAM,YACNC,KAAM,YACNC,KAAM,GACNC,YAAa,oMACbC,QAAS,wBACTC,aAAc,CACd,CACE,KAAQ,oBACR,SAAY,gDAEd,CACE,KAAQ,gBACR,SAAY,8CAEd,CACE,KAAQ,cACR,SAAY,mDAEd,CACE,KAAQ,kBACR,SAAY,+CAEd,CACE,KAAQ,kBACR,SAAY,0DAGdC,WAAY,2KAEd,CACEP,GAAI,aACJC,KAAM,aACNC,KAAM,WACNC,KAAM,GACNC,YAAa,uKACbC,QAAS,kFACTC,aAAc,CACd,CACE,KAAQ,mBACR,SAAY,kDAGdC,WAAY,4FAEd,CACEP,GAAI,aACJC,KAAM,aACNC,KAAM,WACNC,KAAM,GACNC,YAAa,uRACbC,QAAS,iCACTC,aAAc,CACd,CACE,KAAQ,iBACR,SAAY,+CAEd,CACE,KAAQ,sBACR,SAAY,yDAEd,CACE,KAAQ,eACR,SAAY,yCAEd,CACE,KAAQ,mBACR,SAAY,iDAEd,CACE,KAAQ,iBACR,SAAY,yDAEd,CACE,KAAQ,cACR,SAAY,yDAGdC,WAAY,wQAEd,CACEP,GAAI,aACJC,KAAM,aACNC,KAAM,WACNC,KAAM,GACNC,YAAa,oOACbC,QAAS,iCACTC,aAAc,CACd,CACE,KAAQ,kBACR,KAAQ,WACR,SAAY,+CAEd,CACE,KAAQ,iBACR,KAAQ,qBACR,SAAY,uDAGdC,WAAY,+LAEd,CACEP,GAAI,iBACJC,KAAM,aACNC,KAAM,YACNC,KAAM,GACNC,YAAa,oJACbC,QAAS,mFACTC,aAAc,CACZ,CACE,KAAQ,iBACR,SAAY,yDAGhBC,WAAY,kGAGd,CACEP,GAAI,OACJC,KAAM,OACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,8NACbC,QAAS,oCACTC,aAAc,CACZ,CAAE,KAAQ,iBAAkB,SAAY,wDACxC,CAAE,KAAQ,eAAgB,SAAY,sDACtC,CAAE,KAAQ,uBAAwB,SAAY,oDAC9C,CAAE,KAAQ,iBAAkB,SAAY,wDACxC,CAAE,KAAQ,mBAAoB,SAAY,0DAE5CC,WAAY,+KAId,CACEP,GAAI,gBACJC,KAAM,gBACNC,KAAM,WACNC,KAAM,GACNC,YAAa,6JACbC,QAAS,+BACTC,aAAc,CACZ,CAAE,KAAQ,qBAAsB,SAAY,iDAC5C,CAAE,KAAQ,oBAAqB,SAAY,iDAC3C,CAAE,KAAQ,gBAAiB,SAAY,+DACvC,CAAE,KAAQ,gBAAiB,SAAY,uDACvC,CAAE,KAAQ,wBAAyB,SAAY,kDAC/C,CAAE,KAAQ,oBAAqB,SAAY,4DAE7CC,WAAY,0JAGd,CACEP,GAAI,qBACJC,KAAM,qBACNC,KAAM,YACNC,KAAM,GACNC,YAAa,sMACbC,QAAS,2DACTC,aAAc,CACZ,CAAE,KAAQ,aAAc,SAAY,0CACpC,CAAE,KAAQ,gBAAiB,SAAY,8CACvC,CAAE,KAAQ,mBAAoB,SAAY,8CAC1C,CAAE,KAAQ,UAAW,SAAY,wCAEnCC,WAAY,iLAEd,CACEP,GAAI,sBACJC,KAAM,gBACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,4MACbC,QAAS,2BACTC,aAAc,GACdC,WAAY,+KAMd,CACEP,GAAI,qBACJC,KAAM,qBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,+WACbC,QAAS,2BACTC,aAAc,CACZ,CACE,KAAQ,sBACR,SAAY,qDAGhBC,WAAY,gOAEd,CACEP,GAAI,sBACJC,KAAM,sBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,2SACbC,QAAS,2BACTC,aAAc,CACZ,CACE,KAAQ,cACR,SAAY,6CAGhBC,WAAY,iHAGd,CACEP,GAAI,QACJC,KAAM,QACNC,KAAM,UACNC,KAAM,GACNC,YAAa,wQACbC,QAAS,qBACTC,aAAc,GACdC,WAAY,+EAEd,CACEP,GAAI,mBACJC,KAAM,mBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,8OACbC,QAAS,uBACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,sDAGhBC,WAAY,sKAEd,CACEP,GAAI,uBACJC,KAAM,uBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,uOACbC,QAAS,uCACTC,aAAc,CACZ,CACE,KAAQ,YACR,SAAY,0CAGhBC,WAAY,gHAEd,CACEP,GAAI,eACJC,KAAM,eACNC,KAAM,UACNC,KAAM,GACNC,YAAa,iMACbC,QAAS,8BACTC,aAAc,GACdC,WAAY,6GAEd,CACEP,GAAI,QACJC,KAAM,QACNC,KAAM,UACNC,KAAM,GACNC,YAAa,8TACbC,QAAS,sBACTC,aAAc,GACdC,WAAY,sIAEd,CACEP,GAAI,aACJC,KAAM,aACNC,KAAM,UACNC,KAAM,GACNC,YAAa,mSACbC,QAAS,0BACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,4CAEd,CACE,KAAQ,cACR,SAAY,6DAEd,CACE,KAAQ,YACR,SAAY,mDAEd,CACE,KAAQ,oBACR,SAAY,0DAGhBC,WAAY,kQAEd,CACEP,GAAI,iBACJC,KAAM,iBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,yPACbC,QAAS,6BACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,4CAEd,CACE,KAAQ,YACR,SAAY,mDAEd,CACE,KAAQ,oBACR,SAAY,0DAGhBC,WAAY,mNAEd,CACEP,GAAI,gBACJC,KAAM,gBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,sRACbC,QAAS,gCACTC,aAAc,CACZ,CACE,KAAQ,oBACR,SAAY,kDAEd,CACE,KAAQ,aACR,SAAY,oDAEd,CACE,KAAQ,iBACR,SAAY,+CAEd,CACE,KAAQ,cACR,SAAY,KAGhBC,WAAY,wKAEd,CACEP,GAAI,WACJC,KAAM,WACNC,KAAM,UACNC,KAAM,EACNC,YAAa,4LACbC,QAAS,4CACTC,aAAc,CACZ,CACE,KAAQ,iBACR,SAAY,6DAEd,CACE,KAAQ,eACR,SAAY,6DAGhBC,WAAY,sHAEd,CACEP,GAAI,qBACJC,KAAM,qBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,u1BACbC,QAAS,qCACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,qDAEd,CACE,KAAQ,iBACR,SAAY,iDAEd,CACE,KAAQ,iBACR,SAAY,oDAGhBC,WAAY,4HAEd,CACEP,GAAI,YACJC,KAAM,YACNC,KAAM,UACNC,KAAM,GACNC,YAAa,8gBACbC,QAAS,mCACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,sDAEd,CACE,KAAQ,uBACR,SAAY,8DAEd,CACE,KAAQ,gBACR,SAAY,8CAGhBC,WAAY,uKAEd,CACEP,GAAI,WACJC,KAAM,WACNC,KAAM,UACNC,KAAM,EACNC,YAAa,+oBACbC,QAAS,wBACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,6CAEd,CACE,KAAQ,gBACR,SAAY,wDAGhBC,WAAY,6NAEd,CACEP,GAAI,cACJC,KAAM,cACNC,KAAM,UACNC,KAAM,EACNC,YAAa,6oBACbC,QAAS,2BACTC,aAAc,CACZ,CACE,KAAQ,wBACR,SAAY,6DAEd,CACE,KAAQ,iBACR,SAAY,gDAEd,CACE,KAAQ,cACR,SAAY,oDAEd,CACE,KAAQ,iBACR,SAAY,2CAGhBC,WAAY,wXAEd,CACEP,GAAI,YACJC,KAAM,YACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,+IACbC,QAAS,wBACTC,aAAc,CACZ,CACE,KAAQ,cACR,SAAY,qDAEd,CACE,KAAQ,cACR,SAAY,mDAEd,CACE,KAAQ,yBACR,SAAY,qEAEd,CACE,KAAQ,mBACR,SAAY,6CAEd,CACE,KAAQ,WACR,SAAY,kDAGhBC,WAAY,6HAEd,CACEP,GAAI,iBACJC,KAAM,iBACNC,KAAM,WACNC,KAAM,GACNC,YAAa,gIACbC,QAAS,+BACTC,aAAc,GACdC,WAAY,yDAEd,CACEP,GAAI,oBACJC,KAAM,qBACNC,KAAM,YACNC,KAAM,GACNC,YAAa,8bACbC,QAAS,qBACTC,aAAc,CACZ,CACE,KAAQ,2BACR,SAAY,+CAEd,CACE,KAAQ,eACR,KAAQ,0BACR,SAAY,uDAGhBC,WAAY,kOAEd,CACEP,GAAI,SACJC,KAAM,sBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,6TACbC,QAAS,qBACTC,aAAc,CACZ,CACE,KAAQ,aACR,SAAY,0CAEd,CACE,KAAQ,eACR,SAAY,4CAEd,CACE,KAAQ,sBACR,SAAY,iEAEd,CACE,KAAQ,iBACR,SAAY,yDAGhBC,WAAY,gMAGd,CACEP,GAAI,MACJC,KAAM,MACNC,KAAM,aACNC,KAAM,GACNC,YAAa,0HACbC,QAAS,kBACTC,aAAc,CACd,CACE,KAAQ,kBACR,SAAY,yDAEd,CACE,KAAQ,eACR,SAAY,0CAEd,CACE,KAAQ,eACR,SAAY,8CAGdC,WAAY,yKAEd,CACEP,GAAI,cACJC,KAAM,wBACNC,KAAM,QACNC,KAAM,GACNC,YAAa,mIACbC,QAAS,kCACTC,aAAc,CACd,CACE,KAAQ,uBACR,SAAY,8CAGdC,WAAY,iHAEd,CACEP,GAAI,QACJC,KAAM,mBACNC,KAAM,cACNC,KAAM,GACNC,YAAa,0HACbC,QAAS,wBACTC,aAAc,CACd,CACE,KAAQ,iBACR,SAAY,+CAGdC,WAAY,oFAId,CACEP,GAAI,eACJC,KAAM,eACNC,KAAM,aACNC,KAAM,GACNC,YAAa,qPACbC,QAAS,0BACTC,aAAc,GACdC,WAAY,2JAGd,CACIP,GAAI,iCACJC,KAAM,KACNC,KAAM,aACNC,KAAM,GACNC,YAAa,gRACbC,QAAS,0CACTC,aAAc,GACdC,WAAY,sHAIhB,CACEP,GAAI,WACJC,KAAM,mBACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,wHACbC,QAAS,sBACTC,aAAc,CACd,CACE,KAAQ,uBACR,SAAY,+DAGdC,WAAY,kFAEd,CACEP,GAAI,mBACJC,KAAM,mBACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,6LACbC,QAAS,8BACTC,aAAc,CACd,CACE,KAAQ,iBACR,KAAQ,MACR,SAAY,+CAGdC,WAAY,0FAEd,CACEP,GAAI,SACJC,KAAM,kBACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,gGACbC,QAAS,6BACTC,aAAc,CACd,CACE,KAAQ,YACR,SAAY,yCAEd,CACE,KAAQ,mBACR,SAAY,iDAEd,CACE,KAAQ,qBACR,SAAY,mDAEd,CACE,KAAQ,kBACR,SAAY,wDAEd,CACE,KAAQ,mBACR,SAAY,0CAEd,CACE,KAAQ,eACR,SAAY,sDAGdC,WAAY,iJAEd,CACEP,GAAI,SACJC,KAAM,SACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,iMACbC,QAAS,yBACTC,aAAc,CACd,CACE,KAAQ,kBACR,SAAY,yDAEd,CACE,KAAQ,oBACR,SAAY,2DAGdC,WAAY,uJAId,CACEP,GAAI,cACJC,KAAM,cACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,qKACbC,QAAS,0BACTC,aAAc,CACd,CACE,KAAQ,gBACR,SAAY,uCAEd,CACE,KAAQ,eACR,SAAY,8CAGdC,WAAY,8FAId,CACEP,GAAI,gBACJC,KAAM,QACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,wFACbC,QAAS,oBACTC,aAAc,GACdC,WAAY,4CAEd,CACEP,GAAI,gBACJC,KAAM,kCACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,4DACbC,QAAS,2BACTC,aAAc,CACZ,CACE,KAAQ,iBACR,SAAY,yDAGhBC,WAAY,oCAEd,CACEP,GAAI,0BACJC,KAAM,0BACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,wLACbC,QAAS,yBACTC,aAAc,CACd,CACE,KAAQ,cACR,SAAY,6CAEd,CACE,KAAQ,gBACR,SAAY,wCAEd,CACE,KAAQ,cACR,SAAY,sDAGdC,WAAY,qIAKd,CACEP,GAAI,SACJC,KAAM,sBACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,wNACbC,QAAS,6BACTC,aAAc,CACd,CACE,KAAQ,eACR,SAAY,sDAGdC,WAAY,qHAEd,CACEP,GAAI,YACJC,KAAM,YACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,wKACbC,QAAS,2BACTC,aAAc,CACd,CACE,KAAQ,gBACR,SAAY,sDAEd,CACE,KAAQ,aACR,SAAY,2CAGdC,WAAY,iJAEd,CACEP,GAAI,gBACJC,KAAM,iBACNC,KAAM,YACNC,KAAM,GACNC,YAAa,qMACbC,QAAS,iDACTC,aAAc,CACd,CACE,KAAQ,gBACR,KAAQ,aACR,SAAY,6CAEd,CACE,KAAQ,cACR,KAAQ,uBACR,SAAY,4CAEd,CACE,KAAQ,iBACR,KAAQ,iCACR,SAAY,8CAEd,CACE,KAAQ,YACR,KAAQ,UACR,SAAY,2CAEd,CACE,KAAQ,kBACR,KAAQ,mBACR,SAAY,yDAEd,CACE,KAAQ,cACR,KAAQ,mBACR,SAAY,+CAGdC,WAAY,gHAEd,CACEP,GAAI,kBACJC,KAAM,kBACNC,KAAM,YACNC,KAAM,GACNC,YAAa,6LACbC,QAAS,iCACTC,aAAc,GACdC,WAAY,+FAGd,CACEP,GAAI,gCACJC,KAAM,OACNC,KAAM,YACNC,KAAM,GACNC,YAAa,iTACbC,QAAS,uCACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,oDAGdC,WAAY,kLAId,CACEP,GAAI,YACJC,KAAM,yBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,8KACbC,QAAS,0BACTC,aAAc,CACd,CACE,KAAQ,cACR,SAAY,iDAGdC,WAAY,kKAEd,CACEP,GAAI,iBACJC,KAAM,iBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,0NACbC,QAAS,+BACTC,aAAc,CACd,CACE,KAAQ,oBACR,KAAQ,wBACR,SAAY,4CAGdC,WAAY,oGAEd,CACEP,GAAI,WACJC,KAAM,WACNC,KAAM,UACNC,KAAM,GACNC,YAAa,mIACbC,QAAS,uBACTC,aAAc,CACd,CACE,KAAQ,iBACR,SAAY,yDAGdC,WAAY,gGAEd,CACEP,GAAI,OACJC,KAAM,eACNC,KAAM,UACNC,KAAM,GACNC,YAAa,iFACbC,QAAS,mBACTC,aAAc,CACd,CACE,KAAQ,gBACR,SAAY,2DAEd,CACE,KAAQ,YACR,SAAY,2CAGdC,WAAY,uGAEd,CACEP,GAAI,SACJC,KAAM,qBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,sHACbC,QAAS,wBACTC,aAAc,CACd,CACE,KAAQ,iBACR,SAAY,yDAEd,CACE,KAAQ,gBACR,SAAY,wDAGdC,WAAY,iGAEd,CACEP,GAAI,aACJC,KAAM,iBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,qIACbC,QAAS,4BACTC,aAAc,CACd,CACE,KAAQ,eACR,SAAY,6CAEd,CACE,KAAQ,kBACR,SAAY,0DAGdC,WAAY,uGAEd,CACEP,GAAI,YACJC,KAAM,YACNC,KAAM,UACNC,KAAM,GACNC,YAAa,2PACbC,QAAS,4DACTC,aAAc,CACd,CACE,KAAQ,gBACR,SAAY,uDAGdC,WAAY,8GAGd,CACEP,GAAI,SACJC,KAAM,SACNC,KAAM,UACNC,KAAM,GACNC,YAAa,qKACbC,QAAS,qBACTC,aAAc,GACdC,WAAY,8DAEd,CACEP,GAAI,QACJC,KAAM,QACNC,KAAM,YACNC,KAAM,GACNC,YAAa,yNACbC,QAAS,gCACTC,aAAc,GACdC,WAAY,+HAEd,CACEP,GAAI,OACJC,KAAM,OACNC,KAAM,YACNC,KAAM,GACNC,YAAa,yMACbC,QAAS,wBACTC,aAAc,CACd,CACE,KAAQ,oBACR,SAAY,0DAEd,CACE,KAAQ,kBACR,SAAY,0DAGdC,WAAY,qFAEd,CACEP,GAAI,OACJC,KAAM,OACNC,KAAM,KACNC,KAAM,GACNC,YAAa,4MACbC,QAAS,wEACTC,aAAc,CACd,CACE,KAAQ,eACR,SAAY,uDAGdC,WAAY,mFAEd,CACEP,GAAI,UACJC,KAAM,UACNC,KAAM,UACNC,KAAM,GACNC,YAAa,4LACbC,QAAS,2CACTC,aAAc,CACd,CACE,KAAQ,eACR,SAAY,uDAGdC,WAAY,uDAEd,CACEP,GAAI,YACJC,KAAM,YACNC,KAAM,UACNC,KAAM,GACNC,YAAa,+GACbC,QAAS,wBACTC,aAAc,CACd,CACE,KAAQ,gBACR,SAAY,uDAEd,CACE,KAAQ,oBACR,SAAY,2DAGdC,WAAY,uDAEd,CACEP,GAAI,mBACJC,KAAM,UACNC,KAAM,UACNC,KAAM,GACNC,YAAa,oOACbC,QAAS,8BACTC,aAAc,CACd,CACE,KAAQ,aACR,SAAY,6CAEd,CACE,KAAQ,cACR,SAAY,0CAGdC,WAAY,2IAEd,CACEP,GAAI,iBACJC,KAAM,kBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,0PACbC,QAAS,gCACTC,aAAc,CACd,CACE,KAAQ,qBACR,SAAY,2DAEd,CACE,KAAQ,mBACR,SAAY,gDAEd,CACE,KAAQ,eACR,SAAY,6CAEd,CACE,KAAQ,aACR,SAAY,iDAEd,CACE,KAAQ,mBACR,SAAY,gDAEd,CACE,KAAQ,iBACR,SAAY,+CAEd,CACE,KAAQ,kBACR,SAAY,4CAGdC,WAAY,0GAEd,CACEP,GAAI,gBACJC,KAAM,gBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,oHACbC,QAAS,0BACTC,aAAc,GACdC,WAAY,sGAEd,CACEP,GAAI,SACJC,KAAM,SACNC,KAAM,UACNC,KAAM,GACNC,YAAa,0OACbC,QAAS,qBACTC,aAAc,CACd,CACE,KAAQ,eACR,SAAY,6CAGdC,WAAY,oHAEd,CACEP,GAAI,aACJC,KAAM,0BACNC,KAAM,UACNC,KAAM,GACNC,YAAa,0QACbC,QAAS,0BACTC,aAAc,CACd,CACE,KAAQ,oBACR,SAAY,kDAEd,CACE,KAAQ,wBACR,SAAY,gEAGdC,WAAY,2LAEd,CACEP,GAAI,eACJC,KAAM,eACNC,KAAM,UACNC,KAAM,GACNC,YAAa,0MACbC,QAAS,2BACTC,aAAc,CACd,CACE,KAAQ,cACR,SAAY,gDAGdC,WAAY,wJAEd,CACEP,GAAI,mBACJC,KAAM,WACNC,KAAM,YACNC,KAAM,GACNC,YAAa,qQACbC,QAAS,wBACTC,aAAc,CACd,CACE,KAAQ,cACR,SAAY,oDAEd,CACE,KAAQ,aACR,SAAY,qDAEd,CACE,KAAQ,cACR,SAAY,2CAGdC,WAAY,gKAEd,CACEP,GAAI,WACJC,KAAM,WACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,iPACbC,QAAS,2BACTC,aAAc,CACd,CACE,KAAQ,eACR,SAAY,4CAEd,CACE,KAAQ,qBACR,SAAY,kDAGdC,WAAY,uLAEd,CACEP,GAAI,oBACJC,KAAM,oBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,wLACbC,QAAS,6BACTC,aAAc,CACd,CACE,KAAQ,uBACR,SAAY,yDAEd,CACE,KAAQ,cACR,SAAY,qDAEd,CACE,KAAQ,mBACR,SAAY,sDAGdC,WAAY,+JAEd,CACEP,GAAI,UACJC,KAAM,UACNC,KAAM,UACNC,KAAM,GACNC,YAAa,yLACbC,QAAS,uBACTC,aAAc,CACd,CACE,KAAQ,oBACR,SAAY,8CAGdC,WAAY,kJAEd,CACEP,GAAI,iBACJC,KAAM,iBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,mJACbC,QAAS,6BACTC,aAAc,CACZ,CACE,KAAQ,YACR,SAAY,oDAGhBC,WAAY,iGAEd,CACE,GAAM,0BACN,KAAQ,0BACR,KAAQ,UACR,KAAQ,EACR,YAAe,4JACf,QAAW,8BACX,aAAgB,GAChB,WAAc,8GAEhB,CACEP,GAAI,aACJC,KAAM,aACNC,KAAM,UACNC,KAAM,GACNC,YAAa,+RACbC,QAAS,8BACTC,aAAc,CACZ,CACE,KAAQ,kBACR,SAAY,2DAGhBC,WAAY,wKAEd,CACEP,GAAI,sBACJC,KAAM,sBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,6QACbC,QAAS,wBACTC,aAAc,CACZ,CACE,KAAQ,gBACR,SAAY,gDAGhBC,WAAY,0IAEd,CACEP,GAAI,eACJC,KAAM,gBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,sVACbC,QAAS,yBACTC,aAAc,CACZ,CACE,KAAQ,4BACR,SAAY,4DAEd,CACE,KAAQ,gBACR,SAAY,sDAGhBC,WAAY,0OAEd,CACEP,GAAI,SACJC,KAAM,SACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,6YACbC,QAAS,yBACTC,aAAc,CACZ,CACE,KAAQ,gBACR,SAAY,8CAGhBC,WAAY,uRAEd,CACEP,GAAI,kBACJC,KAAM,kBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,mOACbC,QAAS,+BACTC,aAAc,CACZ,CACE,KAAQ,cACR,SAAY,qDAEd,CACE,KAAQ,aACR,SAAY,2CAGhBC,WAAY,2JAEd,CACEP,GAAI,uBACJC,KAAM,uBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,6PACbC,QAAS,8BACTC,aAAc,CACZ,CACE,KAAQ,oBACR,SAAY,+CAGhBC,WAAY,0LAEd,CACEP,GAAI,aACJC,KAAM,aACNC,KAAM,UACNC,KAAM,GACNC,YAAa,8RACbC,QAAS,oCACTC,aAAc,CACZ,CACE,KAAQ,cACR,SAAY,qDAEd,CACE,KAAQ,mBACR,SAAY,8CAEd,CACE,KAAQ,eACR,SAAY,sDAGhBC,WAAY,qOAEd,CACEP,GAAI,kBACJC,KAAM,kBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,+NACbC,QAAS,mCACTC,aAAc,CACZ,CACE,KAAQ,cACR,SAAY,2CAEd,CACE,KAAQ,kBACR,SAAY,+CAEd,CACE,KAAQ,iBACR,SAAY,yDAGhBC,WAAY,4LAEd,CACEP,GAAI,gBACJC,KAAM,gBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,6PACbC,QAAS,iCACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,4CAEd,CACE,KAAQ,oBACR,SAAY,mDAGhBC,WAAY,oMAEd,CACEP,GAAI,UACJC,KAAM,UACNC,KAAM,kBACNC,KAAM,GACNC,YAAa,0WACbC,QAAS,sBACTC,aAAc,GACdC,WAAY,6OAEd,CACEP,GAAI,SACJC,KAAM,SACNC,KAAM,UACNC,KAAM,EACNC,YAAa,4VACbC,QAAS,yBACTC,aAAc,CACZ,CACE,KAAQ,oBACR,SAAY,gDAGhBC,WAAY,+MAEd,CACEP,GAAI,YACJC,KAAM,YACNC,KAAM,UACNC,KAAM,GACNC,YAAa,qYACbC,QAAS,2BACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,qDAEd,CACE,KAAQ,2BACR,SAAY,yCAGhBC,WAAY,yNAEd,CACEP,GAAI,WACJC,KAAM,2BACNC,KAAM,UACNC,KAAM,GACNC,YAAa,qVACbC,QAAS,uBACTC,aAAc,CACZ,CACE,KAAQ,cACR,SAAY,oDAEd,CACE,KAAQ,eACR,SAAY,qDAEd,CACE,KAAQ,eACR,SAAY,4CAEd,CACE,KAAQ,eACR,SAAY,6CAGhBC,WAAY,uNAEd,CACEP,GAAI,UACJC,KAAM,UACNC,KAAM,UACNC,KAAM,GACNC,YAAa,oZACbC,QAAS,0BACTC,aAAc,CACZ,CACE,KAAQ,YACR,SAAY,yCAEd,CACE,KAAQ,UACR,SAAY,uCAEd,CACE,KAAQ,iBACR,SAAY,yDAGhBC,WAAY,8MAEd,CACEP,GAAI,WACJC,KAAM,uBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,0QACbC,QAAS,yBACTC,aAAc,CACZ,CACE,KAAQ,iBACR,SAAY,sDAEd,CACE,KAAQ,mBACR,SAAY,0DAEd,CACE,KAAQ,cACR,SAAY,qDAEd,CACE,KAAQ,eACR,SAAY,sDAGhBC,WAAY,2RAEd,CACEP,GAAI,UACJC,KAAM,uBACNC,KAAM,UACNC,KAAM,EACNC,YAAa,+SACbC,QAAS,sBACTC,aAAc,CACZ,CACE,KAAQ,kBACR,SAAY,uCAEd,CACE,KAAQ,kBACR,SAAY,gDAGhBC,WAAY,4RAEd,CACEP,GAAI,eACJC,KAAM,eACNC,KAAM,UACNC,KAAM,GACNC,YAAa,0QACbC,QAAS,0BACTC,aAAc,CACZ,CACE,KAAQ,cACR,SAAY,oDAEd,CACE,KAAQ,gBACR,SAAY,sDAEd,CACE,KAAQ,gBACR,SAAY,8CAEd,CACE,KAAQ,mBACR,SAAY,iDAGhBC,WAAY,2QAEd,CACEP,GAAI,UACJC,KAAM,uBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,8RACbC,QAAS,sCACTC,aAAc,CACZ,CACE,KAAQ,sBACR,SAAY,8DAEd,CACE,KAAQ,kBACR,SAAY,yDAEd,CACE,KAAQ,gBACR,SAAY,+DAEd,CACE,KAAQ,WACR,SAAY,iDAGhBC,WAAY,+NAEd,CACEP,GAAI,WACJC,KAAM,iBACNC,KAAM,iBACNC,KAAM,GACNC,YAAa,qQACbC,QAAS,wBACTC,aAAc,CACZ,CACE,KAAQ,kBACR,SAAY,yDAEd,CACE,KAAQ,gBACR,SAAY,8CAEd,CACE,KAAQ,eACR,SAAY,sDAEd,CACE,KAAQ,aACR,SAAY,2CAGhBC,WAAY,sOAEd,CACEP,GAAI,QACJC,KAAM,gBACNC,KAAM,UACNC,KAAM,GACNC,YAAa,6SACbC,QAAS,+BACTC,aAAc,CACZ,CACE,KAAQ,eACR,SAAY,8CAGhBC,WAAY,qPAEd,CACEP,GAAI,aACJC,KAAM,aACNC,KAAM,UACNC,KAAM,GACNC,YAAa,2SACbC,QAAS,8BACTC,aAAc,CACZ,CACE,KAAQ,kBACR,SAAY,2DAGhBC,WAAY,2PAEd,CACEP,GAAI,cACJC,KAAM,eACNC,KAAM,UACNC,KAAM,GACNC,YAAa,iUACbC,QAAS,8BACTC,aAAc,CACZ,CACE,KAAQ,iBACR,SAAY,oDAGhBC,WAAY,+RAIhBC,MAAO,CAEL,CAAEC,OAAQ,QAASC,OAAQ,SAAUR,KAAM,gBAAiBE,YAAa,sDACzE,CAAEK,OAAQ,QAASC,OAAQ,MAAOR,KAAM,gBAAiBE,YAAa,iCACtE,CAAEK,OAAQ,QAASC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,yBAC5E,CAAEK,OAAQ,SAAUC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,yBAC7E,CAAEK,OAAQ,QAASC,OAAQ,MAAOR,KAAM,gBAAiBE,YAAa,kCACtE,CAAEK,OAAQ,QAASC,OAAQ,OAAQR,KAAM,gBAAiBE,YAAa,gEACvE,CAAEK,OAAQ,SAAUC,OAAQ,OAAQR,KAAM,gBAAiBE,YAAa,gEACxE,CAAEK,OAAQ,QAASC,OAAQ,mBAAoBR,KAAM,cAAeE,YAAa,kGACjF,CAAEK,OAAQ,mBAAoBC,OAAQ,WAAYR,KAAM,QAASE,YAAa,0FAC9E,CAAEK,OAAQ,iBAAkBC,OAAQ,mBAAoBR,KAAM,QAASE,YAAa,uGACpF,CAAEK,OAAQ,iBAAkBC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,0GACjF,CAAEK,OAAQ,WAAYC,OAAQ,WAAYR,KAAM,cAAeE,YAAa,wEAC5E,CAAEK,OAAQ,QAASC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,oFACxE,CAAEK,OAAQ,YAAaC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,oEAC5E,CAAEK,OAAQ,eAAgBC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,gGAC/E,CAAEK,OAAQ,eAAgBC,OAAQ,SAAUR,KAAM,gBAAiBE,YAAa,kHAChF,CAAEK,OAAQ,eAAgBC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,qGACnF,CAAEK,OAAQ,eAAgBC,OAAQ,MAAOR,KAAM,gBAAiBE,YAAa,0FAC7E,CAAEK,OAAQ,eAAgBC,OAAQ,QAASR,KAAM,iBAAkBE,YAAa,mGAChF,CAAEK,OAAQ,eAAgBC,OAAQ,OAAQR,KAAM,iBAAkBE,YAAa,sEAG/E,CAAEK,OAAQ,iCAAkCC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,mIACjG,CAAEK,OAAQ,iCAAkCC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,0GACrG,CAAEK,OAAQ,iCAAkCC,OAAQ,SAAUR,KAAM,gBAAiBE,YAAa,8GAClG,CAAEK,OAAQ,iCAAkCC,OAAQ,eAAgBR,KAAM,cAAeE,YAAa,8IAEtG,CAAEK,OAAQ,mBAAoBC,OAAQ,SAAUR,KAAM,gBAAiBE,YAAa,uFACpF,CAAEK,OAAQ,mBAAoBC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,oGACnF,CAAEK,OAAQ,mBAAoBC,OAAQ,MAAOR,KAAM,gBAAiBE,YAAa,qFACjF,CAAEK,OAAQ,mBAAoBC,OAAQ,MAAOR,KAAM,gBAAiBE,YAAa,gHAEjF,CAAEK,OAAQ,MAAOC,OAAQ,iBAAkBR,KAAM,iBAAkBE,YAAa,sHAEhF,CAAEK,OAAQ,QAASC,OAAQ,OAAQR,KAAM,iBAAkBE,YAAa,4GACxE,CAAEK,OAAQ,iBAAkBC,OAAQ,gBAAiBR,KAAM,iBAAkBE,YAAa,gIAC1F,CAAEK,OAAQ,SAAUC,OAAQ,gBAAiBR,KAAM,iBAAkBE,YAAa,0JAClF,CAAEK,OAAQ,SAAUC,OAAQ,gBAAiBR,KAAM,iBAAkBE,YAAa,uHAGlF,CAAEK,OAAQ,qBAAsBC,OAAQ,cAAeR,KAAM,cAAeE,YAAa,uMACzF,CAAEK,OAAQ,QAASC,OAAQ,sBAAuBR,KAAM,iBAAkBE,YAAa,+IAIvF,CAAEK,OAAQ,SAAUC,OAAQ,qBAAsBR,KAAM,UAAWE,YAAa,kFAChF,CAAEK,OAAQ,SAAUC,OAAQ,gBAAiBR,KAAM,UAAWE,YAAa,wEAG3E,CAAEK,OAAQ,QAASC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,iCACnE,CAAEK,OAAQ,QAASC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,4BACnE,CAAEK,OAAQ,QAASC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,sCACnE,CAAEK,OAAQ,QAASC,OAAQ,aAAcR,KAAM,UAAWE,YAAa,4BACvE,CAAEK,OAAQ,QAASC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,0CACnE,CAAEK,OAAQ,QAASC,OAAQ,mBAAoBR,KAAM,UAAWE,YAAa,6FAC7E,CAAEK,OAAQ,SAAUC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,wCACpE,CAAEK,OAAQ,SAAUC,OAAQ,YAAaR,KAAM,UAAWE,YAAa,sCACvE,CAAEK,OAAQ,SAAUC,OAAQ,YAAaR,KAAM,UAAWE,YAAa,+BACvE,CAAEK,OAAQ,SAAUC,OAAQ,OAAQR,KAAM,UAAWE,YAAa,+BAClE,CAAEK,OAAQ,SAAUC,OAAQ,WAAYR,KAAM,UAAWE,YAAa,iDACtE,CAAEK,OAAQ,WAAYC,OAAQ,QAASR,KAAM,UAAWE,YAAa,0JACrE,CAAEK,OAAQ,SAAUC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,0CACpE,CAAEK,OAAQ,SAAUC,OAAQ,aAAcR,KAAM,UAAWE,YAAa,0FACxE,CAAEK,OAAQ,SAAUC,OAAQ,iBAAkBR,KAAM,UAAWE,YAAa,gFAC5E,CAAEK,OAAQ,SAAUC,OAAQ,mBAAoBR,KAAM,UAAWE,YAAa,8EAC9E,CAAEK,OAAQ,QAASC,OAAQ,aAAcR,KAAM,gBAAiBE,YAAa,uGAC7E,CAAEK,OAAQ,SAAUC,OAAQ,YAAaR,KAAM,UAAWE,YAAa,+BAGvE,CAAEK,OAAQ,SAAUC,OAAQ,YAAaR,KAAM,aAAcE,YAAa,6DAC1E,CAAEK,OAAQ,SAAUC,OAAQ,YAAaR,KAAM,aAAcE,YAAa,8DAC1E,CAAEK,OAAQ,SAAUC,OAAQ,SAAUR,KAAM,aAAcE,YAAa,yDACvE,CAAEK,OAAQ,gBAAiBC,OAAQ,SAAUR,KAAM,eAAgBE,YAAa,oFAChF,CAAEK,OAAQ,OAAQC,OAAQ,UAAWR,KAAM,aAAcE,YAAa,iDACtE,CAAEK,OAAQ,OAAQC,OAAQ,YAAaR,KAAM,aAAcE,YAAa,8DACxE,CAAEK,OAAQ,WAAYC,OAAQ,SAAUR,KAAM,aAAcE,YAAa,wBAEzE,CAAEK,OAAQ,WAAYC,OAAQ,gBAAiBR,KAAM,aAAcE,YAAa,gHAChF,CAAEK,OAAQ,WAAYC,OAAQ,iBAAkBR,KAAM,aAAcE,YAAa,uFACjF,CAAEK,OAAQ,WAAYC,OAAQ,0BAA2BR,KAAM,aAAcE,YAAa,kFAC1F,CAAEK,OAAQ,WAAYC,OAAQ,SAAUR,KAAM,aAAcE,YAAa,+CACzE,CAAEK,OAAQ,WAAYC,OAAQ,YAAaR,KAAM,aAAcE,YAAa,8CAC5E,CAAEK,OAAQ,WAAYC,OAAQ,mBAAoBR,KAAM,aAAcE,YAAa,wCACnF,CAAEK,OAAQ,MAAOC,OAAQ,iBAAkBR,KAAM,YAAaE,YAAa,+CAG3E,CAAEK,OAAQ,OAAQC,OAAQ,SAAUR,KAAM,cAAeE,YAAa,2BACtE,CAAEK,OAAQ,WAAYC,OAAQ,SAAUR,KAAM,cAAeE,YAAa,2BAC1E,CAAEK,OAAQ,OAAQC,OAAQ,WAAYR,KAAM,UAAWE,YAAa,8BACpE,CAAEK,OAAQ,OAAQC,OAAQ,eAAgBR,KAAM,UAAWE,YAAa,oEACxE,CAAEK,OAAQ,WAAYC,OAAQ,OAAQR,KAAM,UAAWE,YAAa,kCACpE,CAAEK,OAAQ,YAAaC,OAAQ,WAAYR,KAAM,UAAWE,YAAa,gCACzE,CAAEK,OAAQ,YAAaC,OAAQ,iBAAkBR,KAAM,UAAWE,YAAa,sEAE/E,CAAEK,OAAQ,QAASC,OAAQ,OAAQR,KAAM,cAAeE,YAAa,2CACrE,CAAEK,OAAQ,QAASC,OAAQ,OAAQR,KAAM,cAAeE,YAAa,mCAGrE,CAAEK,OAAQ,QAASC,OAAQ,QAASR,KAAM,cAAeE,YAAa,wEAEtE,CAAEK,OAAQ,QAASC,OAAQ,OAAQR,KAAM,SAAUE,YAAa,qFAChE,CAAEK,OAAQ,QAASC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,kGACnE,CAAEK,OAAQ,QAASC,OAAQ,YAAaR,KAAM,YAAaE,YAAa,qEAGxE,CAAEK,OAAQ,SAAUC,OAAQ,iBAAkBR,KAAM,cAAeE,YAAa,kCAChF,CAAEK,OAAQ,QAASC,OAAQ,iBAAkBR,KAAM,YAAaE,YAAa,wDAC7E,CAAEK,OAAQ,iBAAkBC,OAAQ,SAAUR,KAAM,SAAUE,YAAa,iBAC3E,CAAEK,OAAQ,SAAUC,OAAQ,QAASR,KAAM,oBAAqBE,YAAa,2HAC7E,CAAEK,OAAQ,SAAUC,OAAQ,YAAaR,KAAM,oBAAqBE,YAAa,8GAEjF,CAAEK,OAAQ,SAAUC,OAAQ,SAAUR,KAAM,cAAeE,YAAa,iHACxE,CAAEK,OAAQ,SAAUC,OAAQ,gBAAiBR,KAAM,SAAUE,YAAa,qDAC1E,CAAEK,OAAQ,SAAUC,OAAQ,WAAYR,KAAM,SAAUE,YAAa,gDACrE,CAAEK,OAAQ,SAAUC,OAAQ,gBAAiBR,KAAM,SAAUE,YAAa,qDAC1E,CAAEK,OAAQ,SAAUC,OAAQ,aAAcR,KAAM,SAAUE,YAAa,kDACvE,CAAEK,OAAQ,SAAUC,OAAQ,gBAAiBR,KAAM,SAAUE,YAAa,qDAC1E,CAAEK,OAAQ,SAAUC,OAAQ,cAAeR,KAAM,SAAUE,YAAa,mDACxE,CAAEK,OAAQ,SAAUC,OAAQ,sBAAuBR,KAAM,SAAUE,YAAa,2DAChF,CAAEK,OAAQ,SAAUC,OAAQ,SAAUR,KAAM,SAAUE,YAAa,8CACnE,CAAEK,OAAQ,YAAaC,OAAQ,MAAOR,KAAM,gBAAiBE,YAAa,2IAC1E,CAAEK,OAAQ,WAAYC,OAAQ,QAASR,KAAM,UAAWE,YAAa,+EACrE,CAAEK,OAAQ,WAAYC,OAAQ,MAAOR,KAAM,UAAWE,YAAa,mFACnE,CAAEK,OAAQ,UAAWC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,4EAC1E,CAAEK,OAAQ,UAAWC,OAAQ,MAAOR,KAAM,UAAWE,YAAa,yCAClE,CAAEK,OAAQ,WAAYC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,+GAC3E,CAAEK,OAAQ,UAAWC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,6OAC1E,CAAEK,OAAQ,eAAgBC,OAAQ,QAASR,KAAM,UAAWE,YAAa,8LACzE,CAAEK,OAAQ,WAAYC,OAAQ,WAAYR,KAAM,aAAcE,YAAa,8FAC3E,CAAEK,OAAQ,WAAYC,OAAQ,YAAaR,KAAM,aAAcE,YAAa,mHAC5E,CAAEK,OAAQ,WAAYC,OAAQ,UAAWR,KAAM,aAAcE,YAAa,gGAC1E,CAAEK,OAAQ,WAAYC,OAAQ,WAAYR,KAAM,aAAcE,YAAa,yIAC3E,CAAEK,OAAQ,WAAYC,OAAQ,UAAWR,KAAM,aAAcE,YAAa,yFAC1E,CAAEK,OAAQ,WAAYC,OAAQ,eAAgBR,KAAM,aAAcE,YAAa,iHAC/E,CAAEK,OAAQ,WAAYC,OAAQ,WAAYR,KAAM,aAAcE,YAAa,+GAE3E,CAAEK,OAAQ,WAAYC,OAAQ,OAAQR,KAAM,cAAeE,YAAa,8CAExE,CAAEK,OAAQ,YAAaC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,4BAC5E,CAAEK,OAAQ,YAAaC,OAAQ,SAAUR,KAAM,gBAAiBE,YAAa,mCAC7E,CAAEK,OAAQ,YAAaC,OAAQ,aAAcR,KAAM,UAAWE,YAAa,2GAC3E,CAAEK,OAAQ,QAASC,OAAQ,aAAcR,KAAM,iBAAkBE,YAAa,wGAC9E,CAAEK,OAAQ,YAAaC,OAAQ,QAASR,KAAM,cAAeE,YAAa,yFAC1E,CAAEK,OAAQ,YAAaC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,6GAGhF,CAAEK,OAAQ,SAAUC,OAAQ,aAAcR,KAAM,cAAeE,YAAa,6HAC5E,CAAEK,OAAQ,aAAcC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,4GACjF,CAAEK,OAAQ,aAAcC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,2FAC7E,CAAEK,OAAQ,aAAcC,OAAQ,oBAAqBR,KAAM,UAAWE,YAAa,mGACnF,CAAEK,OAAQ,aAAcC,OAAQ,UAAWR,KAAM,UAAWE,YAAa,mGACzE,CAAEK,OAAQ,YAAaC,OAAQ,UAAWR,KAAM,UAAWE,YAAa,oJACxE,CAAEK,OAAQ,YAAaC,OAAQ,mBAAoBR,KAAM,UAAWE,YAAa,mGACjF,CAAEK,OAAQ,YAAaC,OAAQ,aAAcR,KAAM,UAAWE,YAAa,sGAC3E,CAAEK,OAAQ,YAAaC,OAAQ,eAAgBR,KAAM,UAAWE,YAAa,yHAC7E,CAAEK,OAAQ,YAAaC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,iHACvE,CAAEK,OAAQ,OAAQC,OAAQ,eAAgBR,KAAM,UAAWE,YAAa,iHAGxE,CAAEK,OAAQ,SAAUC,OAAQ,aAAcR,KAAM,cAAeE,YAAa,kFAC5E,CAAEK,OAAQ,aAAcC,OAAQ,aAAcR,KAAM,gBAAiBE,YAAa,0GAClF,CAAEK,OAAQ,aAAcC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,8FACjF,CAAEK,OAAQ,SAAUC,OAAQ,mBAAoBR,KAAM,yBAA0BE,YAAa,8DAE7F,CAAEK,OAAQ,iCAAkCC,OAAQ,OAAQR,KAAM,QAASE,YAAa,+EACxF,CAAEK,OAAQ,iCAAkCC,OAAQ,UAAWR,KAAM,gBAAiBE,YAAa,gHACnG,CAAEK,OAAQ,iCAAkCC,OAAQ,SAAUR,KAAM,WAAYE,YAAa,4FAC7F,CAAEK,OAAQ,OAAQC,OAAQ,iCAAkCR,KAAM,cAAeE,YAAa,6BAC9F,CAAEK,OAAQ,SAAUC,OAAQ,MAAOR,KAAM,cAAeE,YAAa,6CACrE,CAAEK,OAAQ,gBAAiBC,OAAQ,MAAOR,KAAM,cAAeE,YAAa,+BAM5E,CAAEK,OAAQ,cAAeC,OAAQ,YAAaR,KAAM,UAAWE,YAAa,uCAC5E,CAAEK,OAAQ,WAAYC,OAAQ,QAASR,KAAM,UAAWE,YAAa,wCACrE,CAAEK,OAAQ,SAAUC,OAAQ,mBAAoBR,KAAM,UAAWE,YAAa,iDAC9E,CAAEK,OAAQ,0BAA2BC,OAAQ,mBAAoBR,KAAM,gBAAiBE,YAAa,4HAErG,CAAEK,OAAQ,SAAUC,OAAQ,OAAQR,KAAM,UAAWE,YAAa,2FAClE,CAAEK,OAAQ,SAAUC,OAAQ,sBAAuBR,KAAM,UAAWE,YAAa,8EACjF,CAAEK,OAAQ,SAAUC,OAAQ,QAASR,KAAM,UAAWE,YAAa,wGACnE,CAAEK,OAAQ,SAAUC,OAAQ,mBAAoBR,KAAM,QAASE,YAAa,kGAG5E,CAAEK,OAAQ,MAAOC,OAAQ,QAASR,KAAM,UAAWE,YAAa,iGAChE,CAAEK,OAAQ,MAAOC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,kGACjE,CAAEK,OAAQ,MAAOC,OAAQ,MAAOR,KAAM,UAAWE,YAAa,mGAC9D,CAAEK,OAAQ,MAAOC,OAAQ,YAAaR,KAAM,UAAWE,YAAa,+EACpE,CAAEK,OAAQ,MAAOC,OAAQ,MAAOR,KAAM,UAAWE,YAAa,yFAE9D,CAAEK,OAAQ,MAAOC,OAAQ,WAAYR,KAAM,cAAeE,YAAa,+IACvE,CAAEK,OAAQ,MAAOC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,iEACjE,CAAEK,OAAQ,MAAOC,OAAQ,YAAaR,KAAM,UAAWE,YAAa,mGACpE,CAAEK,OAAQ,MAAOC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,+EACjE,CAAEK,OAAQ,MAAOC,OAAQ,UAAWR,KAAM,UAAWE,YAAa,iFAClE,CAAEK,OAAQ,MAAOC,OAAQ,mBAAoBR,KAAM,UAAWE,YAAa,iFAC3E,CAAEK,OAAQ,MAAOC,OAAQ,iBAAkBR,KAAM,UAAWE,YAAa,wEACzE,CAAEK,OAAQ,MAAOC,OAAQ,mBAAoBR,KAAM,UAAWE,YAAa,gFAE3E,CAAEK,OAAQ,gCAAiCC,OAAQ,QAASR,KAAM,cAAeE,YAAa,mIAC9F,CAAEK,OAAQ,gCAAiCC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,qHACpG,CAAEK,OAAQ,gCAAiCC,OAAQ,YAAaR,KAAM,gBAAiBE,YAAa,+GACpG,CAAEK,OAAQ,gCAAiCC,OAAQ,MAAOR,KAAM,gBAAiBE,YAAa,uHAG9F,CAAEK,OAAQ,gCAAiCC,OAAQ,iBAAkBR,KAAM,UAAWE,YAAa,8FACnG,CAAEK,OAAQ,gCAAiCC,OAAQ,aAAcR,KAAM,UAAWE,YAAa,uFAC/F,CAAEK,OAAQ,gCAAiCC,OAAQ,WAAYR,KAAM,UAAWE,YAAa,mGAC7F,CAAEK,OAAQ,gCAAiCC,OAAQ,aAAcR,KAAM,UAAWE,YAAa,mGAC/F,CAAEK,OAAQ,gCAAiCC,OAAQ,mBAAoBR,KAAM,UAAWE,YAAa,gGACrG,CAAEK,OAAQ,gCAAiCC,OAAQ,cAAeR,KAAM,UAAWE,YAAa,+FAChG,CAAEK,OAAQ,gCAAiCC,OAAQ,eAAgBR,KAAM,UAAWE,YAAa,+FACjG,CAAEK,OAAQ,OAAQC,OAAQ,QAASR,KAAM,UAAWE,YAAa,4EAGjE,CAAEK,OAAQ,iBAAkBC,OAAQ,iBAAkBR,KAAM,SAAUE,YAAa,kHACnF,CAAEK,OAAQ,sBAAuBC,OAAQ,iBAAkBR,KAAM,SAAUE,YAAa,oIACxF,CAAEK,OAAQ,qBAAsBC,OAAQ,iBAAkBR,KAAM,SAAUE,YAAa,6HACvF,CAAEK,OAAQ,SAAUC,OAAQ,iBAAkBR,KAAM,WAAYE,YAAa,8JAG7E,CAAEK,OAAQ,aAAcC,OAAQ,QAASR,KAAM,UAAWE,YAAa,mIACvE,CAAEK,OAAQ,aAAcC,OAAQ,YAAaR,KAAM,UAAWE,YAAa,qCAC3E,CAAEK,OAAQ,iBAAkBC,OAAQ,QAASR,KAAM,UAAWE,YAAa,sGAC3E,CAAEK,OAAQ,iBAAkBC,OAAQ,YAAaR,KAAM,UAAWE,YAAa,qCAG/E,CAAEK,OAAQ,aAAcC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,4TACxE,CAAEK,OAAQ,aAAcC,OAAQ,gBAAiBR,KAAM,SAAUE,YAAa,8NAC9E,CAAEK,OAAQ,gBAAiBC,OAAQ,gBAAiBR,KAAM,SAAUE,YAAa,uHAGjF,CAAEK,OAAQ,sBAAuBC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,gMACjF,CAAEK,OAAQ,sBAAuBC,OAAQ,QAASR,KAAM,UAAWE,YAAa,4LAGhF,CAAEK,OAAQ,kBAAmBC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,2MASlF,CAAEK,OAAQ,WAAYC,OAAQ,YAAaR,KAAM,aAAcE,YAAa,0GAG5E,CAAEK,OAAQ,UAAWC,OAAQ,iBAAkBR,KAAM,SAAUE,YAAa,6FAC5E,CAAEK,OAAQ,UAAWC,OAAQ,MAAOR,KAAM,gBAAiBE,YAAa,qGACxE,CAAEK,OAAQ,UAAWC,OAAQ,QAASR,KAAM,gBAAiBE,YAAa,mHAC1E,CAAEK,OAAQ,UAAWC,OAAQ,SAAUR,KAAM,gBAAiBE,YAAa,+GAC3E,CAAEK,OAAQ,kBAAmBC,OAAQ,UAAWR,KAAM,UAAWE,YAAa,sHAG9E,CAAEK,OAAQ,uBAAwBC,OAAQ,SAAUR,KAAM,gBAAiBE,YAAa,6JAGxF,CAAEK,OAAQ,aAAcC,OAAQ,SAAUR,KAAM,UAAWE,YAAa,uMACxE,CAAEK,OAAQ,aAAcC,OAAQ,MAAOR,KAAM,UAAWE,YAAa,6JAGrE,CAAEK,OAAQ,kBAAmBC,OAAQ,mBAAoBR,KAAM,cAAeE,YAAa,sLAG3F,CAAEK,OAAQ,gBAAiBC,OAAQ,SAAUR,KAAM,SAAUE,YAAa,0KAC1E,CAAEK,OAAQ,gBAAiBC,OAAQ,SAAUR,KAAM,gBAAiBE,YAAa,kJAGjF,CAAEK,OAAQ,QAASC,OAAQ,MAAOR,KAAM,cAAeE,YAAa,iKACpE,CAAEK,OAAQ,QAASC,OAAQ,QAASR,KAAM,cAAeE,YAAa,gJACtE,CAAEK,OAAQ,QAASC,OAAQ,SAAUR,KAAM,cAAeE,YAAa,uIACvE,CAAEK,OAAQ,QAASC,OAAQ,cAAeR,KAAM,cAAeE,YAAa,yJAG5E,CAAEK,OAAQ,iCAAkCC,OAAQ,cAAeR,KAAM,cAAeE,YAAa,kGAErG,CAAEK,OAAQ,WAAYC,OAAQ,WAAYR,KAAM,aAAcE,YAAa,yIAG3E,CAAEK,OAAQ,qBAAsBC,OAAQ,OAAQR,KAAM,cAAeE,YAAa,sLAClF,CAAEK,OAAQ,qBAAsBC,OAAQ,SAAUR,KAAM,cAAeE,YAAa,yIAO3EO,EAAc,CACvBC,QAAS,UACTC,eAAgB,UAChBC,QAAS,UACTC,WAAY,sBACZC,qBAAsB,sBACtBC,cAAe,2BACfC,GAAI,WACJC,YAAa,0BACbC,UAAW,0BACXC,SAAU,0BACVC,WAAY,yBACZC,MAAO,yBACPC,YAAa,yBACbC,gBAAiB,mBACjBC,IAAK,mBACLC,SAAU,mBACVC,WAAY,mBACZC,UAAW,qBAIFC,EAAa,CACtB,sBAAuB,UACvB,QAAW,UACX,SAAY,UACZ,0BAA2B,UAC3B,yBAA0B,UAC1B,mBAAoB,UACpB,QAAW,UACX,2BAA4B,UAC5B,oBAAqB,U","sources":["atlanta_biotech_data.js"],"sourcesContent":["/*\n * Copyright (c) 2025 Benjamin Siciliano\n * All rights reserved.\n * \n * This file is part of the benjaminsiciliano.com project.\n * Unauthorized copying, modification, distribution, or use is strictly prohibited.\n * For licensing inquiries, contact: ben.siciliano@gmail.com\n */\n\nexport const atlantaBiotechEcosystem = {\n  nodes: [\n    // UNIVERSITIES & RESEARCH INSTITUTIONS\n    {\n      id: \"emory\",\n      name: \"Emory University\",\n      type: \"university\",\n      size: 25,\n      description: \"Leading private research university with over $1B in sponsored research funding. A major source of biomedical innovation and biotech spinouts like Altesa, NeurOp, and GeoVax.\",\n      website: \"https://emory.edu\",\n      keyPersonnel: [\n      {\n        \"name\": \"Wilbur Lam\",\n        \"linkedin\": \"https://www.linkedin.com/in/wilbur-a-lam-5b84a667/\"\n      },\n      {\n        \"name\": \"Morgan Greenleaf\",\n        \"linkedin\": \"https://www.linkedin.com/in/morgan-greenleaf/\"\n      },\n      {\n        \"name\": \"C. Michael Cassidy\",\n        \"linkedin\": \"https://www.linkedin.com/in/michael-cassidy-14867130/\"\n      },\n      {\n        \"name\": \"Todd Polley\",\n        \"linkedin\": \"https://www.linkedin.com/in/polley/\"\n      }\n    ],\n      recentNews: \"Emory launches Center for New Medicines to accelerate academic drug discovery.\"\n    },\n    {\n      id: \"gatech\",\n      name: \"Georgia Tech\",\n      type: \"university\",\n      size: 23,\n      description: \"Top public engineering and research university. Home to the ATDC incubator and CREATE-X startup programs. A hub for medtech innovation, spinning out companies like Micron, Clearside, and OXOS.\",\n      website: \"https://gatech.edu\",\n      keyPersonnel: [\n      {\n        \"name\": \"Mark Prausnitz\",\n        \"linkedin\": \"https://www.linkedin.com/in/mark-prausnitz-61a46423/\"\n      },\n      {\n        \"name\": \"Raghupathy Sivakumar\",\n        \"linkedin\": \"https://www.linkedin.com/in/sivarag/\"\n      },\n      {\n        \"name\": \"Marvin Whiteley\",\n        \"linkedin\": \"https://www.linkedin.com/in/marvin-whiteley-895997194/\"\n      }\n    ],\n      recentNews: \"CREATE-X announced a record cohort of 318 founders in 2025. Science Square Phase 1 completed in 2024.\"\n    },\n    {\n      id: \"morehouse\",\n      name: \"MSM\",\n      type: \"university\",\n      size: 15,\n      description: \"Morehouse School of Medicine (MSM) - historically Black medical school focused on health equity. Partner in the Georgia Clinical & Translational Science Alliance (CTSA).\",\n      website: \"https://msm.edu\",\n      keyPersonnel: [\n      {\n        \"name\": \"Valerie Montgomery Rice\",\n        \"linkedin\": \"https://www.linkedin.com/in/valerie-montgomery-rice-473015201/\"\n      }\n    ],\n      recentNews: \"Celebrating 50th anniversary in 2025. Key partner in Georgia CTSA.\"\n    },\n    {\n      id: \"uga\",\n      name: \"UGA\",\n      type: \"university\",\n      size: 18,\n      description: \"Major public research university with strengths in veterinary medicine, pharmacy, and agricultural biotech. A key partner in statewide innovation initiatives through GRA.\",\n      website: \"https://uga.edu\",\n      keyPersonnel: [\n      {\n        \"name\": \"Jere W. Morehead\",\n        \"linkedin\": \"https://www.linkedin.com/in/jeremorehead/\"\n      }\n    ],\n      recentNews: \"Partner in statewide biotech initiatives via GRA.\"\n    },\n    {\n      id: \"gsu\",\n      name: \"GSU\",\n      type: \"university\",\n      size: 16,\n      description: \"Research university with growing programs in infectious disease and neuroscience. Key collaborator on public health initiatives.\",\n      website: \"https://www.gsu.edu\",\n      keyPersonnel: [\n      {\n        \"name\": \"M. Brian Blake\",\n        \"linkedin\": \"https://www.linkedin.com/in/m-brian-blake/\"\n      }\n    ],\n      recentNews: \"GSU and Emory co-lead NIH's Antiviral Countermeasures Development Center\"\n    },\n\n    {\n      id: \"cdc\",\n      name: \"CDC\",\n      type: \"government\",\n      size: 20,\n      description: \"U.S. Centers for Disease Control and Prevention. A major federal anchor for public health and infectious disease research, headquartered in Atlanta.\",\n      website: \"https://cdc.gov\",\n      keyPersonnel: [\n      {\n        \"name\": \"Dr. Mandy K. Cohen\",\n        \"linkedin\": \"https://www.linkedin.com/in/mandy-cohen-03aa343/\"\n      }\n    ],\n      recentNews: \"Expanding lab capacity and forming industry partnerships with Roche and Quest for global health initiatives.\"\n    },\n    {\n      id: \"choa\",\n      name: \"CHOA\",\n      type: \"health_system\",\n      size: 20,\n      description: \"One of the largest pediatric healthcare systems in the U.S., CHOA is a leading site for pediatric clinical trials, translational research, and academic partnerships with Emory and Georgia Tech. Hosts the Marcus Autism Center and Children's Center for Clinical and Translational Research.\",\n      website: \"https://www.choa.org/\",\n      keyPersonnel: [],\n      recentNews: \"CHOA and Emory lead NIH-funded national trial to improve outcomes in extremely preterm infants.\"\n    },\n    {\n      id: \"emory_healthcare\",\n      name: \"Emory Healthcare\",\n      type: \"health_system\",\n      size: 19,\n      description: \"Emory's clinical enterprise and the largest health system in Georgia. Operates the Emory Healthcare Innovation Hub (EHIH), which partners with startups and global firms to validate digital health and AI solutions in clinical settings.\",\n      website: \"https://www.emoryhealthcare.org/\",\n      keyPersonnel: [],\n      recentNews: \"Emory Healthcare partners with Galileo to expand primary care access through digital and in-person services.\"\n    },\n    {\n      id: \"wellstar\",\n      name: \"Wellstar Health System\",\n      type: \"health_system\",\n      size: 18,\n      description: \"One of the largest health systems in Georgia, operating hospitals, urgent care, and specialty centers. Parent organization of Catalyst by Wellstar, the system's innovation and venture arm.\",\n      website: \"https://www.wellstar.org\",\n      keyPersonnel: [],\n      recentNews: \"Wellstar files for new 230-bed hospital in Acworth and invests over $1.4 billion in major expansions statewide.\"\n    },\n    {\n      id: \"grady\",\n      name: \"Grady\",\n      type: \"health_system\",\n      size: 17,\n      description: \"Atlanta's largest safety-net hospital and trauma center. Key clinical research site and community health partner for Emory, Morehouse, and Georgia CTSA programs.\",\n      website: \"https://www.gradyhealth.org\",\n      keyPersonnel: [],\n      recentNews: \"Grady named as Learning Phase site for NIH Equitable Breakthroughs in Medicine initiative, partnering with Morehouse and Emory.\"\n    },\n    {\n      id: \"oak_street_health\",\n      name: \"Oak Street Health\",\n      type: \"health_system\",\n      size: 14,\n      description: \"Value-based primary care provider with multiple clinics across Atlanta serving Medicare and elderly populations. Often partners with digital health and aging-focused innovators.\",\n      website: \"https://www.oakstreethealth.com\",\n      keyPersonnel: [],\n      recentNews: \"Oak Street continues to grow its clinic network in Georgia and expand partnerships with health tech innovators.\"\n    },\n    {\n      id: \"aveanna_healthcare\",\n      name: \"Aveanna Healthcare\",\n      type: \"health_system\",\n      size: 17,\n      description: \"Atlanta-headquartered national leader in pediatric and adult home health, hospice, and private‑duty nursing. Supports aging‑care pilots and partnerships with healthtech innovators.\",\n      website: \"https://www.aveanna.com\",\n      keyPersonnel: [],\n      recentNews: \"Corporate HQ based in Atlanta; serves over 300 locations across 33 states; active in home‑based healthcare innovation and population health partnership pilots.\"\n    },\n    {\n      id: \"piedmont_healthcare\",\n      name: \"Piedmont Healthcare\",\n      type: \"health_system\",\n      size: 16,\n      description: \"Atlanta-based health system operating hospitals and clinics across Georgia. Known for major construction projects including Marcus Tower and partnerships with healthtech providers.\",\n      website: \"https://www.piedmont.org\",\n      keyPersonnel: [],\n      recentNews: \"Piedmont Healthcare completes Phase I of Marcus Tower at Piedmont Atlanta Hospital.\"\n    },\n\n    // MAJOR COMPANIES - CLINICAL STAGE\n\n    {\n      id: \"geovax\",\n      name: \"GeoVax Labs\",\n      type: \"public_company\",\n      size: 12,\n      description: \"Clinical-stage vaccine and immunotherapy company. An Emory spinout developing novel vaccine technologies for infectious diseases and cancer.\",\n      website: \"https://geovax.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"David Dodd\",\n        \"linkedin\": \"https://www.linkedin.com/in/david-a-dodd-3b28616/\"\n      }\n    ],\n      recentNews: \"Advancing Phase 2 clinical trials for its next-gen COVID-19 vaccine.\"\n    },\n    {\n      id: \"micron\",\n      name: \"Micron Biomedical\",\n      type: \"startup\",\n      size: 16,\n      description: \"Georgia Tech spinout developing a dissolvable microneedle patch for painless, needle-free delivery of drugs and vaccines.\",\n      website: \"https://micronbiomedical.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Steven Damon\",\n        \"linkedin\": \"https://www.linkedin.com/in/steven-damon-a1966a5/\"\n      }\n    ],\n      recentNews: \"Micron Biomedical completed first-in-human influenza vaccine patch trial and published results.\"\n    },\n    {\n      id: \"neurop\",\n      name: \"NeurOp\",\n      type: \"startup\",\n      size: 14,\n      description: \"Clinical-stage CNS drug developer. A spinout from research at Emory and Duke University.\",\n      website: \"http://neuropinc.com/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Raymond Dingledine\",\n        \"linkedin\": \"https://www.linkedin.com/in/ray-dingledine-41669821/\"\n      }\n    ],\n      recentNews: \"FDA granted Orphan Drug Designation for NP10679 in subarachnoid hemorrhage (SAH).\"\n    },\n\n\n    // GROWTH COMPANIES\n\n    {\n      id: \"maphabit\",\n      name: \"MapHabit\",\n      type: \"company\",\n      size: 16,\n      description: \"Digital health company providing evidence-based cognitive support tools for individuals with intellectual and developmental disabilities (IDD) and dementia-related conditions. Platform uses personalized, step-by-step visual guides to increase independence and improve quality of life.\",\n      website: \"https://maphabit.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Matt Golden\",\n        \"linkedin\": \"https://www.linkedin.com/in/mattgolden756/\"\n      }\n    ],\n      recentNews: \"Georgia Medicaid now covers MapHabit for individuals with IDD. Partnered with CVS Health, United Healthcare, Avesis, and BCBS. $11M in NIH grant funding awarded in May 2024.\"\n    },\n    {\n      id: \"florence\",\n      name: \"Florence Healthcare\",\n      type: \"company\",\n      size: 17,\n      description: \"Leading eClinical software company providing an electronic Trial Master File (eTMF) platform. Series C funding totaled $107M ($80M + $27M).\",\n      website: \"https://florencehc.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Ryan Jones\",\n        \"linkedin\": \"https://www.linkedin.com/in/adventurejones/\"\n      }\n    ],\n      recentNews: \"Florence Healthcare network surpasses 37,000 research sites globally.\"\n    },\n    {\n      id: \"clearside\",\n      name: \"Clearside Biomedical\",\n      type: \"public_company\",\n      size: 16,\n      description: \"Biopharmaceutical company developing treatments for sight-threatening diseases. A Georgia Tech spinout commercializing a proprietary microinjector technology.\",\n      website: \"https://clearsidebio.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Dr. George Lasezkay\",\n        \"linkedin\": \"https://www.linkedin.com/in/george-lasezkay-1848679/\"\n      }\n    ],\n      recentNews: \"Clearside reports positive 6-month results from Phase 2b OASIS trial in wet AMD.\"\n    },\n    {\n      id: \"vero\",\n      name: \"VERO Biotech\",\n      type: \"company\",\n      size: 17,\n      description: \"Medtech company with an FDA-approved inhaled nitric oxide system (Genosyl®) for neonatal respiratory failure.\",\n      website: \"https://vero-biotech.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Brent V. Furse\",\n        \"linkedin\": \"https://www.linkedin.com/in/brentfurse/\"\n      }\n    ],\n      recentNews: \"Relocating HQ and manufacturing to Atlanta. Developing next-gen inhaled nitric oxide delivery systems.\"\n    },\n    {\n      id: \"artivion\",\n      name: \"Artivion\",\n      type: \"public_company\",\n      size: 18,\n      description: \"Formerly CryoLife, a global leader in cardiac and vascular surgery solutions.\",\n      website: \"https://artivion.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Pat Mackin\",\n        \"linkedin\": \"https://www.linkedin.com/in/pat-mackin-223aa7151/\"\n      }\n    ],\n      recentNews: \"Launched On-X Plus 1.5™ mechanical heart valve in Europe.\"\n    },\n    {\n      id: \"copient_health\",\n      name: \"Copient Health\",\n      type: \"company\",\n      size: 8,\n      description: \"Healthcare technology company that provides solutions that improve OR scheduling efficiency in both hospitals and surgery centers. Founded in 2019, headquartered in Atlanta, Georgia.\",\n      website: \"https://copienthealth.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Burke Michael\",\n        \"linkedin\": \"https://www.linkedin.com/in/burke-michael/\"\n      },\n      {\n        \"name\": \"Keyton Weissinger\",\n        \"linkedin\": \"https://www.linkedin.com/in/keytonweissinger/\"\n      },\n      {\n        \"name\": \"Kathryn Farrell\",\n        \"linkedin\": \"https://www.linkedin.com/in/kathrynkfarrell/\"\n      },\n      {\n        \"name\": \"Amy Pecic\",\n        \"linkedin\": \"https://www.linkedin.com/in/amy-pecic-b287a4/\"\n      }\n    ],\n      recentNews: \"Provides three main modules: Reclaim (machine learning to identify unused block time), Distribute (connect open time with providers), and Measure and Manage (analytics for OR scheduling).\"\n    },\n\n    // VENTURE CAPITAL & INVESTORS\n    {\n      id: \"portal\",\n      name: \"Portal Innovations\",\n      type: \"vc\",\n      size: 20,\n      description: \"Life sciences venture development engine combining seed capital with 33,000 sq ft of managed lab space at Science Square.\",\n      website: \"https://portalinnovations.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Eddie Lai\",\n        \"linkedin\": \"https://www.linkedin.com/in/edwarddlai/\"\n      },\n      {\n        \"name\": \"Ashley Cornelison\",\n        \"linkedin\": \"https://www.linkedin.com/in/ashley-cornelison/\"\n      }\n    ],\n      recentNews: \"Made first Atlanta investment in Moonlight Therapeutics. Partnered with Novo Nordisk on 'Pathbreakers' program.\"\n    },\n    {\n      id: \"catalyst\",\n      name: \"Catalyst by Wellstar\",\n      type: \"vc\",\n      size: 18,\n      description: \"Corporate venture fund and innovation arm of Wellstar Health System, investing in early-stage digital health and medtech.\",\n      website: \"https://catalyst.wellstar.org\",\n      keyPersonnel: [\n      {\n        \"name\": \"Hank Capps\",\n        \"linkedin\": \"https://www.linkedin.com/in/hankcapps/\"\n      },\n      {\n        \"name\": \"Jaimie Clark\",\n        \"linkedin\": \"https://www.linkedin.com/in/jaimiesclark/\"\n      },\n      {\n        \"name\": \"Stefanie Diaz\",\n        \"linkedin\": \"https://www.linkedin.com/in/thestefaniediaz/\"\n      }\n    ],\n      recentNews: \"Has made over 21 startup investments and provides pilot opportunities within the Wellstar health system.\"\n    },\n    {\n      id: \"bip\",\n      name: \"BIP Ventures\",\n      type: \"vc\",\n      size: 16,\n      description: \"Atlanta-based VC firm (formerly Panoramic Ventures) that invests across technology sectors, including a significant practice in health IT.\",\n      website: \"https://bipventures.vc\",\n      keyPersonnel: [\n      {\n        \"name\": \"Austin Poole\",\n        \"linkedin\": \"https://www.linkedin.com/in/austinmpoole/\"\n      },\n      {\n        \"name\": \"Tami McQueen\",\n        \"linkedin\": \"https://www.linkedin.com/in/tamimcqueen/\"\n      }\n    ],\n      recentNews: \"Actively investing across Seed to Series B, with portfolio companies like OncoLens and The Rounds.\"\n    },\n\n    {\n      id: \"gra_fund\",\n      name: \"GRA Venture Fund\",\n      type: \"vc\",\n      size: 14,\n      description: \"State-affiliated seed fund that invests exclusively in companies emerging from Georgia's research universities.\",\n      website: \"https://gra.org/venture-fund/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Connor Seabrook\",\n        \"linkedin\": \"https://www.linkedin.com/in/connor-seabrook-4659553/\"\n      }\n    ],\n      recentNews: \"Co-invests alongside private VCs in Georgia research spinouts, requiring a 3:1 private match.\"\n    },\n\n    {\n      id: \"keiretsu_southeast\",\n      name: \"Keiretsu Forum South-East\",\n      type: \"vc\",\n      size: 16,\n      description: \"World's largest accredited investor community with 2,250+ members across 53 chapters. South-East chapter encompasses Miami and Atlanta, investing in software, telecommunications, health/life sciences, biotech, and other high-growth areas.\",\n      website: \"http://keiretsuforum-southeast.com/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Barry Etra\",\n        \"linkedin\": \"https://www.linkedin.com/in/barryetra/\"\n      }\n    ],\n      recentNews: \"Co-hosting Southeast Investor Conference with ATDC and Angel Capital Association (July 29-30, 2025) at Georgia Tech.\"\n    },\n\n\n\n\n    // ACCELERATORS & INCUBATORS\n    {\n      id: \"atdc\",\n      name: \"ATDC\",\n      type: \"incubator\",\n      size: 18,\n      description: \"Georgia Tech's state-chartered technology incubator (founded 1980). Features a dedicated HealthTech track in partnership with Wellstar.\",\n      website: \"https://atdc.org\",\n      keyPersonnel: [\n      {\n        \"name\": \"John Avery\",\n        \"linkedin\": \"https://www.linkedin.com/in/johnwavery/\"\n      }\n    ],\n      recentNews: \"Serves 150+ startups and has helped companies secure over $125M in SBIR grants.\"\n    },\n    {\n      id: \"create_x\",\n      name: \"CREATE-X\",\n      type: \"incubator\",\n      size: 16,\n      description: \"Georgia Tech initiative providing funding and mentorship to student and faculty founders. Has launched over 650 startups since 2014.\",\n      website: \"https://create-x.gatech.edu\",\n      keyPersonnel: [\n      {\n        \"name\": \"Raghupathy Sivakumar\",\n        \"linkedin\": \"https://www.linkedin.com/in/sivarag/\"\n      }\n    ],\n      recentNews: \"Expanded AI Health vertical. Alumni include Stord and OXOS.\"\n    },\n    {\n      id: \"biolocity\",\n      name: \"Biolocity\",\n      type: \"incubator\",\n      size: 15,\n      description: \"Joint Emory-GT commercialization accelerator that provides seed funding, project management, and technical guidance to advance promising university medical technologies toward market readiness.\",\n      website: \"https://biolocity.org\",\n      keyPersonnel: [\n      {\n        \"name\": \"Angela Gill Nelms\",\n        \"linkedin\": \"https://www.linkedin.com/in/angelagillnelms/\"\n      },\n      {\n        \"name\": \"Rifat Pamukcu\",\n        \"linkedin\": \"https://www.linkedin.com/in/rifat-pamukcu/\"\n      },\n      {\n        \"name\": \"Brian Walsh\",\n        \"linkedin\": \"https://www.linkedin.com/in/brian-walsh-1bb681/\"\n      },\n      {\n        \"name\": \"Manuel Kingsley\",\n        \"linkedin\": \"https://www.linkedin.com/in/manuelkingsley/\"\n      },\n      {\n        \"name\": \"Jessie Buckelew\",\n        \"linkedin\": \"https://www.linkedin.com/in/jessie-buckelew-24868b8a/\"\n      }\n    ],\n      recentNews: \"Supports translational research through strategic grants and mentorship. Operates in collaboration with Emory and Georgia Tech to de-risk early-stage medtech projects.\"\n    },\n    {\n      id: \"lab2launch\",\n      name: \"Lab2Launch\",\n      type: \"facility\",\n      size: 14,\n      description: \"Wet lab and co-working space at Emory's HSRB II Innovation Floor, providing bench space and infrastructure to Emory-affiliated startups supported through Biolocity.\",\n      website: \"https://med.emory.edu/research/research-innovation/entrepreneurship/lab2launch/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Morgan Greenleaf\",\n        \"linkedin\": \"https://www.linkedin.com/in/morgan-greenleaf/\"\n      }\n          ],\n      recentNews: \"Opened in early 2023; residents benefit from Biolocity network and core facility access.\"\n    },\n    {\n      id: \"quadrant_i\",\n      name: \"Quadrant-i\",\n      type: \"facility\",\n      size: 15,\n      description: \"Georgia Tech's innovation acceleration hub transforming disruptive research into scalable startups. Quadrant-i empowers faculty and students through expert-led commercialization strategy, venture-building programs, and investor access—bridging research and market impact.\",\n      website: \"https://quadrant-i.gatech.edu/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Harold Solomon\",\n        \"linkedin\": \"https://www.linkedin.com/in/haroldmsolomon/\"\n      },\n      {\n        \"name\": \"Cynthia Lee Sundell\",\n        \"linkedin\": \"https://www.linkedin.com/in/cynthia-sundell-71b21017/\"\n      },\n      {\n        \"name\": \"Jeff Garbers\",\n        \"linkedin\": \"https://www.linkedin.com/in/jgarbers/\"\n      },\n      {\n        \"name\": \"Jonathan Goldman\",\n        \"linkedin\": \"https://www.linkedin.com/in/jonathanagoldman/\"\n      },\n      {\n        \"name\": \"Richard Gruber\",\n        \"linkedin\": \"https://www.linkedin.com/in/richard-gruber-b75327280/\"\n      },\n      {\n        \"name\": \"Paul Joseph\",\n        \"linkedin\": \"https://www.linkedin.com/in/paul-j-joseph-266015240/\"\n      }\n          ],\n      recentNews: \"Launched as Georgia Tech's commercialization powerhouse in 2025. Partners with Technology Licensing to vet and launch startups across medtech, biotech, engineering, and diagnostics. Supports Biolocity teams and collaborates with GT VentureLab and EIR networks.\"\n    },\n    {\n      id: \"venturelab\",\n      name: \"VentureLab\",\n      type: \"facility\",\n      size: 15,\n      description: \"Georgia Tech's startup incubation and customer discovery program. Serves as an NSF I-Corps Node, helping faculty and student innovators across biotech, medtech, AI, and engineering translate research into marketable ventures.\",\n      website: \"https://venturelab.gatech.edu/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Keith McGreggor\",\n        \"role\": \"Director\",\n        \"linkedin\": \"https://www.linkedin.com/in/keithmcgreggor/\"\n      },\n      {\n        \"name\": \"Sara Henderson\",\n        \"role\": \"Associate Director\",\n        \"linkedin\": \"https://www.linkedin.com/in/sara-martin-henderson/\"\n      }\n          ],\n      recentNews: \"Leads Georgia Tech's NSF I-Corps Node and early-stage founder support programs. Works closely with Quadrant-i, CREATE-X, and Biolocity to support translational research commercialization.\"\n    },\n    {\n      id: \"collabtech_gsu\",\n      name: \"CollabTech\",\n      type: \"incubator\",\n      size: 12,\n      description: \"Downtown Atlanta biotech incubator hosted by Georgia State University. Offers lab space and core facilities for early-stage bioscience companies.\",\n      website: \"https://research.gsu.edu/georgia-state-technology-transfer/collabtech-incubator/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Darryle Taylor\",\n          \"linkedin\": \"https://www.linkedin.com/in/darryle-taylor-88171a2b/\"\n        }\n      ],\n      recentNews: \"Part of Georgia State's research commercialization initiatives. Located at 58 Edgewood Avenue.\"\n    },\n\n    {\n      id: \"eidd\",\n      name: \"EIDD\",\n      type: \"serviceProvider\",\n      size: 14,\n      description: \"Translational drug discovery center at Emory University focused on antiviral and small molecule therapeutics. Provides lead optimization, IND-enabling studies, and CMC support for internal and external biotech partners.\",\n      website: \"https://eidd.emory.edu/index.html\",\n      keyPersonnel: [\n        { \"name\": \"George Painter\", \"linkedin\": \"https://www.linkedin.com/in/george-painter-5664aa11/\" },\n        { \"name\": \"Mike Natchus\", \"linkedin\": \"https://www.linkedin.com/in/mike-natchus-26424625/\" },\n        { \"name\": \"Alexander Kolykhalov\", \"linkedin\": \"https://www.linkedin.com/in/alexanderkolykhalov/\" },\n        { \"name\": \"Dana Schneider\", \"linkedin\": \"https://www.linkedin.com/in/dana-schneider-abb18a43/\" },\n        { \"name\": \"Marcus Rodriguez\", \"linkedin\": \"https://www.linkedin.com/in/marcus-rodriguez-9269282/\" }\n      ],\n      recentNews: \"EIDD has supported antiviral drug discovery efforts including molnupiravir (LAGEVRIO) and continues to provide infrastructure for Emory spinouts and licensed therapeutics.\"\n    },\n\n\n    {\n      id: \"biospark_labs\",\n      name: \"BioSpark Labs\",\n      type: \"facility\",\n      size: 12,\n      description: \"Purpose‑built shared wet‑lab, cleanroom, and office facility for early‑stage biotech and life sciences startups at Science Square, Atlanta.\",\n      website: \"https://www.biosparklabs.com\",\n      keyPersonnel: [\n        { \"name\": \"Ryan Nicole Lawler\", \"linkedin\": \"https://www.linkedin.com/in/ryannicolelawler/\" },\n        { \"name\": \"Melissa T. Storey\", \"linkedin\": \"https://www.linkedin.com/in/melissa-t-storey/\" },\n        { \"name\": \"Noriko Walker\", \"linkedin\": \"https://www.linkedin.com/in/noriko-walker-rpa-ccim-4403279/\" },\n        { \"name\": \"Willis Herron\", \"linkedin\": \"https://www.linkedin.com/in/willis-herron-59a01662/\" },\n        { \"name\": \"Tiffany A.C. Mitchell\", \"linkedin\": \"https://www.linkedin.com/in/tiffanyacmitchell/\" },\n        { \"name\": \"Tony Zivalich Jr.\", \"linkedin\": \"https://www.linkedin.com/in/tony-zivalich-jr-a7a680352/\" }\n      ],\n      recentNews: \"BioSpark opened a new 17,000 SF facility in 2023 at Science Square to support biotech startups affiliated with Emory, Georgia Tech, and Georgia State.\"\n    },\n\n    {\n      id: \"tag_digital_health\",\n      name: \"TAG Digital Health\",\n      type: \"community\",\n      size: 18,\n      description: \"Statewide society housed within the Technology Association of Georgia that advances healthcare innovation and digital health across Georgia with events, collaboration, and an ecosystem directory.\",\n      website: \"https://www.tagonline.org/chapters-and-societies/health/\",\n      keyPersonnel: [\n        { \"name\": \"Tracy Slee\", \"linkedin\": \"https://www.linkedin.com/in/tracyslee/\" },\n        { \"name\": \"Aastha Sharma\", \"linkedin\": \"https://www.linkedin.com/in/aasthasharma1/\" },\n        { \"name\": \"Robin M. Hackney\", \"linkedin\": \"https://www.linkedin.com/in/robinmhackney/\" },\n        { \"name\": \"Anita B\", \"linkedin\": \"https://www.linkedin.com/in/anitab/\" }\n      ],\n      recentNews: \"Maintains Georgia's Digital Health Ecosystem directory (~460 orgs), hosts events on medtech, health IT, and equity; sponsors include Northside Hospital, UCB Pharmaceuticals.\"\n    },\n    {\n      id: \"adjust_center_emory\",\n      name: \"ADJUST Center\",\n      type: \"serviceProvider\",\n      size: 12,\n      description: \"The Center for the Advancement of Diagnostics for a Just Society (ADJUST) at Emory University: translational diagnostics incubator focused on equitable diagnostic technology development and validation.\",\n      website: \"https://adjust.emory.edu\",\n      keyPersonnel: [],\n      recentNews: \"Operates a CLIA-certified diagnostics laboratory, supports assay development for public health, and collaborates on pediatric and community health diagnostics translation.\"\n    },\n\n\n\n\n    {\n      id: \"piezo_therapeutics\",\n      name: \"Piezo Therapeutics\",\n      type: \"startup\",\n      size: 12,\n      description: \"Georgia Tech spinout focused on enabling next-gen nucleic acid vaccines and therapeutics via energy-based delivery. Integrating innovations in drug delivery and genetic medicine, Piezo is advancing its delivery platform and investigational therapeutics in collaboration with global pharma and biotech companies to prevent and treat deadly or debilitating diseases.\",\n      website: \"https://www.piezotx.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Gaurav Byagathvalli\",\n          \"linkedin\": \"https://www.linkedin.com/in/gaurav-byagathvalli/\"\n        }\n      ],\n      recentNews: \"Raised $2M in 2023 from seed investors led by Good Ventures; published first human data in 2024; technology licensing with Georgia Tech confirmed; expects major pharmaceutical development deals and clinical data in 2025.\"\n    },\n    {\n      id: \"palate_therapeutics\",\n      name: \"Palate Therapeutics\",\n      type: \"startup\",\n      size: 10,\n      description: \"IndieBio NY06 company working to address the growing prevalence of metabolic diseases including insulin resistance, obesity, and diabetes. Developing an oral oligonucleotide therapy to temporarily alter how sweet foods taste and how they are metabolized to help change patient's food preferences.\",\n      website: \"https://www.palatetx.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Mighten Yip\",\n          \"linkedin\": \"https://www.linkedin.com/in/mighten-yip/\"\n        }\n      ],\n      recentNews: \"Part of IndieBio NY06 cohort. Focuses on metabolic disease therapeutics through oral oligonucleotide therapy.\"\n    },\n\n    {\n      id: \"cordx\",\n      name: \"CorDx\",\n      type: \"company\",\n      size: 18,\n      description: \"Multi-national biotech organization headquartered in Atlanta focused on rapid testing and point-of-care medical device solutions for infectious disease detection, pregnancy, drugs of abuse, and biomarkers. Leverages AI and data science for diagnostic solutions.\",\n      website: \"https://cordx.com/\",\n      keyPersonnel: [],\n      recentNews: \"Cordx showcased 3-in-1 COVID-19/Flu A&B rapid test at ADLM 2025 in Atlanta.\"\n    },\n    {\n      id: \"lucid_scientific\",\n      name: \"Lucid Scientific\",\n      type: \"company\",\n      size: 14,\n      description: \"Atlanta-based biotech company creating Resipher, the world's first real-time cell culture monitor to measure oxygen consumption in standard multi-well plates. Provides continuous insight for cell metabolism research and drug screening.\",\n      website: \"https://lucidsci.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Walker Inman\",\n          \"linkedin\": \"https://www.linkedin.com/in/walker-inman-4954aa8/\"\n        }\n      ],\n      recentNews: \"Founded in 2012. Raised $7M Series A in 2023 led by IAG Capital Partners. Resipher technology used in mitochondrial function research and cell metabolism studies.\"\n    },\n    {\n      id: \"timeless_biosciences\",\n      name: \"Timeless Biosciences\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based biotech startup enabling precision diagnostics and targeted treatment through systems biology models informed by real-world patient data. Focuses on complex chronic conditions through precision medicine approaches.\",\n      website: \"https://www.timelessbiosciences.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Nita Jain\",\n          \"linkedin\": \"https://www.linkedin.com/in/nitajain/\"\n        }\n      ],\n      recentNews: \"Founded in 2024. Early-stage startup focused on precision microbiome therapies for complex chronic diseases.\"\n    },\n    {\n      id: \"strados_labs\",\n      name: \"Strados Labs\",\n      type: \"startup\",\n      size: 10,\n      description: \"Digital health company with FDA-cleared RESP® wearable for continuous respiratory monitoring. Operates in both Philadelphia and Atlanta, supporting clinical trials and decentralized care.\",\n      website: \"https://www.stradoslabs.com\",\n      keyPersonnel: [],\n      recentNews: \"Atlanta office supports decentralized clinical trials and respiratory innovation using RESP® wearable.\"\n    },\n    {\n      id: \"heald\",\n      name: \"Heald\",\n      type: \"company\",\n      size: 10,\n      description: \"Integrated diabetes remission program that focuses on the mind, as much as on the body. Uses atomic habits to create incremental progress in the journey. Doctor-led care team designs personalized healing plans based on lifestyle and physical condition, with app syncing to wearables for real-time progress tracking.\",\n      website: \"https://iheald.com/\",\n      keyPersonnel: [],\n      recentNews: \"Founded in 2023. Specializes in diabetes, healthcare, healthtech, machine learning, and Gen AI. Now eligible for FSA/HSA coverage.\"\n    },\n    {\n      id: \"emtherapro\",\n      name: \"Emtherapro\",\n      type: \"company\",\n      size: 12,\n      description: \"Next generation precision medicine enablement solution for neurodegenerative diseases. Empowers biotech, lifesciences and pharmaceutical companies to develop novel diagnostics and therapies using robust precision medicine approach with proteomics, AI/ML, and systems biology capabilities.\",\n      website: \"https://emtherapro.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Kiran Pandey\",\n          \"linkedin\": \"https://www.linkedin.com/in/kiranpandey/\"\n        },\n        {\n          \"name\": \"Allan Levey\",\n          \"linkedin\": \"https://www.linkedin.com/in/allan-levey-m-d-ph-d-0b8b0ba/\"\n        },\n        {\n          \"name\": \"Duc Duong\",\n          \"linkedin\": \"https://www.linkedin.com/in/duc-duong-6a063b34/\"\n        },\n        {\n          \"name\": \"Nicholas Seyfried\",\n          \"linkedin\": \"https://www.linkedin.com/in/nicholas-seyfried-3a1947/\"\n        }\n      ],\n      recentNews: \"Emory spinout transforming diagnosis and treatment of neurodegenerative diseases through pioneering science, data and insights. Offers comprehensive precision medicine enablement solution with proteomics, drug discovery, and clinical trials capabilities.\"\n    },\n    {\n      id: \"arc_proteomics\",\n      name: \"Arc Proteomics\",\n      type: \"company\",\n      size: 10,\n      description: \"Cutting-edge proteomics company dedicated to advancing drug and biomarker discovery through mass spectrometry-based proteomics. Offers discovery and targeted proteomics solutions using Orbitrap Astral platform for comprehensive proteome analysis.\",\n      website: \"https://arcproteomics.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Kiran Pandey\",\n          \"linkedin\": \"https://www.linkedin.com/in/kiranpandey/\"\n        },\n        {\n          \"name\": \"Duc Duong\",\n          \"linkedin\": \"https://www.linkedin.com/in/duc-duong-6a063b34/\"\n        },\n        {\n          \"name\": \"Nicholas Seyfried\",\n          \"linkedin\": \"https://www.linkedin.com/in/nicholas-seyfried-3a1947/\"\n        }\n      ],\n      recentNews: \"Emory spinout located in Decatur, GA specializing in proteome-wide assays for biomarker discovery. Offers comprehensive, customized proteomics solutions for academic institutions and biotechnology companies.\"\n    },\n    {\n      id: \"orthopreserve\",\n      name: \"OrthoPreserve\",\n      type: \"startup\",\n      size: 8,\n      description: \"Medical technology startup developing an artificial meniscus replacement implant to restore knee joint function. Aims to relieve pain and impairment, allow for quick recovery, and reduce the risk of arthritis and knee replacements in patients with previous meniscus injuries.\",\n      website: \"https://www.orthopreserve.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Jonathan Schwartz\",\n          \"linkedin\": \"https://www.linkedin.com/in/jonathanwschwartz/\"\n        },\n        {\n          \"name\": \"Cyrus Kump\",\n          \"linkedin\": \"https://www.linkedin.com/in/cyrus-kump-69308a91/\"\n        },\n        {\n          \"name\": \"Brendan Baggot\",\n          \"linkedin\": \"https://www.linkedin.com/in/brendan-baggot/\"\n        },\n        {\n          \"name\": \"Max Guillot\",\n          \"linkedin\": \"\"\n        }\n      ],\n      recentNews: \"Founded in 2021. Selected as one of 6 finalists for the Startup Prize: Focus on Health 2025 competition. Meniscus implant currently undergoing pre-clinical testing.\"\n    },\n    {\n      id: \"oridivus\",\n      name: \"Oridivus\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based biotechnology company focused on oral wound healing by leveraging the innate immune system. Specializes in pharma and drug delivery solutions for oral health applications.\",\n      website: \"https://www.linkedin.com/company/oridivus\",\n      keyPersonnel: [\n        {\n          \"name\": \"Nathan Chiappa\",\n          \"linkedin\": \"https://www.linkedin.com/in/nathan-chiappa-phd-1912a4142/\"\n        },\n        {\n          \"name\": \"Steven Goudy\",\n          \"linkedin\": \"https://www.linkedin.com/in/steven-goudy-md-mba-b3ba819/\"\n        }\n      ],\n      recentNews: \"Founded in 2019. Focuses on biotechnology research for oral wound healing through innate immune system modulation.\"\n    },\n    {\n      id: \"paint_therapeutics\",\n      name: \"Paint Therapeutics\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based emerging seed-funded biotechnology company utilizing proprietary drug targeting algorithm to improve localization and duration of action of therapeutic agents in the tissues where they are needed most. Paint's conjugation-based therapeutic development platforms enable rapid generation of clinical lead compounds with new compositions of matter starting from drugs already known to be active. Most advanced platform, PulmoPaint™, targets diseases of the lungs, with lead program for treatment of inflammatory lung diseases on track for IND in 2025. Advancing extensive pipeline of additional PulmoPaint™ products including immune potentiating approaches for lung-resident cancers, treatments for refractory and resistant bacterial lung infections including NTM, and preventive agents for viral respiratory infection prophylaxis.\",\n      website: \"https://www.painttherapeutics.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Bill Reddick\",\n          \"linkedin\": \"https://www.linkedin.com/in/bill-reddick-b042894/\"\n        },\n        {\n          \"name\": \"Eric Springman\",\n          \"linkedin\": \"https://www.linkedin.com/in/ericspringmanphd/\"\n        },\n        {\n          \"name\": \"Mariah Stewart\",\n          \"linkedin\": \"https://www.linkedin.com/in/mariah-stewart-unc/\"\n        }\n      ],\n      recentNews: \"Founded in 2022. Seeking additional funding partners to continue both lead advancement and further platform development.\"\n    },\n    {\n      id: \"nutrivert\",\n      name: \"Nutrivert\",\n      type: \"startup\",\n      size: 10,\n      description: \"Atlanta-based animal health company developing non-antibiotic alternatives for livestock production. Nutrivert LDPP is a synthetic non-antibiotic product that mimics a cell wall component released by all bacteria, reducing inflammation and promoting better growth and feed conversion. Designed to improve livestock health and feed efficiency without relying on antibiotics, targeting the $5.8 billion veterinary livestock antibiotics growth promotion market. Also developing early-stage products for protection against Flu.\",\n      website: \"https://www.nutrivertglobal.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Horace Nalle\",\n          \"linkedin\": \"https://www.linkedin.com/in/horace-nalle-8b7a6030/\"\n        },\n        {\n          \"name\": \"Bernhard Kaltenboeck\",\n          \"linkedin\": \"https://www.linkedin.com/in/bernhard-kaltenboeck-18b32661/\"\n        },\n        {\n          \"name\": \"Peter Selover\",\n          \"linkedin\": \"https://www.linkedin.com/in/peterselover/\"\n        }\n      ],\n      recentNews: \"Winner of the Cade Prize for Creativity and Innovation. GRA portfolio company. Developing alternatives to the $5.8 billion veterinary livestock antibiotics market.\"\n    },\n    {\n      id: \"fibronox\",\n      name: \"FibroNox\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based biotechnology company focused on developing patented first-in-class therapeutics to treat and reverse life-threatening fibrotic diseases. FibroNox has pioneered the development of selective Nox4 inhibitors and Nrf2 activators that have shown robust protection from fibrosis development and promoted the reversal of age-associated established fibrosis. Initial focus is treating idiopathic pulmonary fibrosis (IPF) and fibrosis in Duchenne muscular dystrophy. FibroNox's therapeutics offer the opportunity to reverse age-associated established fibrosis, representing the holy grail for more effective strategies to treat fibrotic diseases.\",\n      website: \"https://fibronox.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Joseph Patti\",\n          \"linkedin\": \"https://www.linkedin.com/in/josephmpatti/\"\n        },\n        {\n          \"name\": \"Louise Hecker\",\n          \"linkedin\": \"https://www.linkedin.com/in/louise-hecker-69ba1915/\"\n        }\n      ],\n      recentNews: \"Founded in 2023. Developing inhaled therapeutic delivery for pulmonary fibrosis with significant advantages over current FDA-approved treatments. Targeting 140,000 IPF patients in the U.S. with 40,000 deaths per year.\"\n    },\n    {\n      id: \"oncospherix\",\n      name: \"OncoSpherix\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based pre-clinical stage oncology drug development company advancing a proprietary platform of first-in-class small molecule therapeutics designed to improve quality of life and survival for people with many forms of cancer by targeting a common feature of solid tumors: the activation of hypoxia inducible factor-1 (HIF-1). Nearly all solid cancers grow faster than their blood supply, leading to regions of low oxygen in tumors and HIF activation, which induces expression of over 100 genes that help tumor cells survive and spread. OncoSpherix has several classes of small molecules that block activation of HIF-1 through novel mechanisms.\",\n      website: \"https://oncospherix.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Margaret K. Offermann\",\n          \"linkedin\": \"https://www.linkedin.com/in/margaret-k-offermann-236b505/\"\n        },\n        {\n          \"name\": \"Erwin Van Meir\",\n          \"linkedin\": \"https://www.linkedin.com/in/erwinvanmeirphd/\"\n        },\n        {\n          \"name\": \"Steve Coats\",\n          \"linkedin\": \"https://www.linkedin.com/in/steve-coats-99a5066/\"\n        },\n        {\n          \"name\": \"Allan Valmonte\",\n          \"linkedin\": \"https://www.linkedin.com/in/avalmonte/\"\n        }\n      ],\n      recentNews: \"Founded in 2018. Lead clinical candidate has been shown in mouse models to reduce primary tumor growth, inhibit metastases, and prolong survival in many types of cancer including glioblastoma, pancreatic cancer, uveal melanoma, lung cancer, and breast cancer. Agents are well tolerated and can be combined with therapeutics that work in well oxygenated regions of cancers.\"\n    },\n    {\n      id: \"emory_ott\",\n      name: \"Emory OTT\",\n      type: \"serviceProvider\",\n      size: 15,\n      description: \"Emory's central technology transfer office, advising researchers on IP, licensing, commercialization, and supporting translational startups.\",\n      website: \"https://ott.emory.edu\",\n      keyPersonnel: [\n        {\n          \"name\": \"Todd Sherer\",\n          \"linkedin\": \"https://www.linkedin.com/in/todd-sherer-0270011a/\"\n        },\n        {\n          \"name\": \"Mark Coburn\",\n          \"linkedin\": \"https://www.linkedin.com/in/mark-coburn-739685/\"\n        },\n        {\n          \"name\": \"Catherine Murari-Kanti\",\n          \"linkedin\": \"https://www.linkedin.com/in/catherine-murari-kanti-ph-d-b6873315/\"\n        },\n        {\n          \"name\": \"Patrick Reynolds\",\n          \"linkedin\": \"https://www.linkedin.com/in/preynolds123/\"\n        },\n        {\n          \"name\": \"Jill Uhl\",\n          \"linkedin\": \"https://www.linkedin.com/in/jill-uhl-027242a/\"\n        }\n      ],\n      recentNews: \"Enabled 231 invention disclosures, 35 licenses, and launched Entrepreneurship Clinic and Bench2Market programs in FY2024.\"\n    },\n    {\n      id: \"science_square\",\n      name: \"Science Square\",\n      type: \"facility\",\n      size: 16,\n      description: \"A 16-acre life sciences research park adjacent to Georgia Tech, developed by GATV. Anchor tenants include Portal Innovations.\",\n      website: \"https://sciencesquareatl.com\",\n      keyPersonnel: [],\n      recentNews: \"368,000 sq ft Phase 1 lab tower completed in Q2 2024.\"\n    },\n    {\n      id: \"oralee_foundation\",\n      name: \"Ora Lee Foundation\",\n      type: \"community\",\n      size: 12,\n      description: \"Ora Lee Smith Cancer Research Foundation - All volunteer-run 501(c)(3) non-profit organization founded by Dr. Hadiyah-Nicole Green to raise funds needed to translate cancer treatments from laboratory into humans. Dr. Green is a multi-disciplinary physicist specializing in targeted cancer therapeutics using laser-activated nanoparticles and immunotherapies to develop biomarker-specific platforms to target, image, and treat malignant tumors.\",\n      website: \"https://oralee.org\",\n      keyPersonnel: [\n        {\n          \"name\": \"Dr. Hadiyah-Nicole Green\",\n          \"linkedin\": \"https://www.linkedin.com/in/drhadiyahgreen/\"\n        },\n        {\n          \"name\": \"Deirdre Powe\",\n          \"role\": \"Director of Development\",\n          \"linkedin\": \"https://www.linkedin.com/in/deirdre-powe-1a2b3c4d/\"\n        }\n      ],\n      recentNews: \"Dr. Green developed Laser-Activated Nano-Therapy (LANT) which completely eliminates tumors in mice over 15 days after a single 10-minute treatment without side effects. Ready for human clinical trials with funding support.\"\n    },\n    {\n      id: \"odylia\",\n      name: \"Odylia Therapeutics\",\n      type: \"company\",\n      size: 14,\n      description: \"Nonprofit biotech developing gene therapies for rare diseases that have no available treatment. Utilizes a unique nonprofit business model to accelerate development of gene therapies for people with rare disease, regardless of prevalence or commercial interest. Focuses on RPGRIP1, USH1C, and NPHP1 gene therapies.\",\n      website: \"https://odylia.org\",\n      keyPersonnel: [\n        {\n          \"name\": \"Arwin Slow\",\n          \"linkedin\": \"https://www.linkedin.com/in/arwinslow/\"\n        },\n        {\n          \"name\": \"Kathryn Post\",\n          \"linkedin\": \"https://www.linkedin.com/in/kathrynpost/\"\n        },\n        {\n          \"name\": \"Heather Hart-Greene\",\n          \"linkedin\": \"https://www.linkedin.com/in/heather-hart-greene-cfre-7911987/\"\n        },\n        {\n          \"name\": \"Jennifer Klein\",\n          \"linkedin\": \"https://www.linkedin.com/in/jennifer-klein-38688287/\"\n        }\n      ],\n      recentNews: \"Announced new pipeline project for NPHP1 retinal dystrophy gene replacement therapy. Partnered with Comend to advance rare disease drug development with innovative patient-driven platform.\"\n    },\n    // GOVERNMENT & TRADE ORGANIZATIONS\n    {\n      id: \"gra\",\n      name: \"GRA\",\n      type: \"government\",\n      size: 18,\n      description: \"Public-private partnership that helps recruit top scientists and fund university research commercialization in Georgia.\",\n      website: \"https://gra.org\",\n      keyPersonnel: [\n      {\n        \"name\": \"Timothy Denning\",\n        \"linkedin\": \"https://www.linkedin.com/in/tim-denning-phd-4b13728b/\"\n      },\n      {\n        \"name\": \"Justin Burns\",\n        \"linkedin\": \"https://www.linkedin.com/in/jburns301/\"\n      },\n      {\n        \"name\": \"Andrew Short\",\n        \"linkedin\": \"https://www.linkedin.com/in/andreweshort/\"\n      }\n    ],\n      recentNews: \"Tim Denning became GRA's fifth president and CEO in November 2023, after serving as vice president for research and economic development at Georgia State University.\"\n    },\n    {\n      id: \"georgia_bio\",\n      name: \"Georgia Life Sciences\",\n      type: \"trade\",\n      size: 16,\n      description: \"The state's life sciences trade association (formerly Georgia Bio), with over 500 members. Hosts the annual Golden Helix Awards.\",\n      website: \"https://www.galifesciences.org/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Maria Thacker-Goethe\",\n        \"linkedin\": \"https://www.linkedin.com/in/mariathacker/\"\n      }\n    ],\n      recentNews: \"Rebranded from Georgia Bio to Georgia Life Sciences in January 2025 to reflect expanded membership and scope.\"\n    },\n    {\n      id: \"rowen\",\n      name: \"Rowen Foundation\",\n      type: \"development\",\n      size: 15,\n      description: \"Developing a 2,000-acre knowledge community in Gwinnett County focused on biotech, agriculture, and environmental tech.\",\n      website: \"https://rowenlife.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Mason Ailstock\",\n        \"linkedin\": \"https://www.linkedin.com/in/masonailstock/\"\n      }\n    ],\n      recentNews: \"Broke ground on infrastructure in 2024 for a new 2,000-acre innovation district.\"\n    },\n\n\n    {\n      id: \"georgia_ctsa\",\n      name: \"Georgia CTSA\",\n      type: \"government\",\n      size: 14,\n      description: \"Georgia Clinical & Translational Science Alliance (Georgia CTSA) is an NIH-funded statewide collaboration accelerating clinical and translational research across Emory, Georgia Tech, Morehouse School of Medicine, and Georgia State University.\",\n      website: \"https://georgiactsa.org\",\n      keyPersonnel: [],\n      recentNews: \"Supports clinical trials infrastructure, pilot grant funding, and translational training programs across Atlanta's research universities and hospitals.\"\n    },\n\n    {\n        id: 'department_of_veterans_affairs',\n        name: 'VA',\n        type: 'government',\n        size: 18,\n        description: \"Atlanta Department of Veterans Affairs - Federal agency providing healthcare to military veterans. Atlanta VA is a key hub for clinical research, pilot testing for biotech/medtech startups, and translational medicine partnerships with universities and local innovators.\",\n        website: 'https://www.va.gov/atlanta-health-care/',\n        keyPersonnel: [],\n        recentNews: \"Partnered with OXOS Medical for portable X-ray pilots; active collaborator via Georgia CTSA, Emory, and Morehouse.\"\n    },\n\n    // SERVICE PROVIDERS & SUPPORT\n    {\n      id: \"mng_labs\",\n      name: \"MNG Laboratories\",\n      type: \"serviceProvider\",\n      size: 12,\n      description: \"Specialized neurogenetics CRO acquired by LabCorp in 2019. Provides testing services to Emory and other institutions.\",\n      website: \"https://mnglabs.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"William Trey Langley\",\n        \"linkedin\": \"https://www.linkedin.com/in/william-trey-langley-17147921/\"\n      }\n    ],\n      recentNews: \"Continues to operate as a specialized neurogenetic testing lab within LabCorp.\"\n    },\n    {\n      id: \"axion_biosystems\",\n      name: \"Axion BioSystems\",\n      type: \"serviceProvider\",\n      size: 15,\n      description: \"Atlanta‑headquartered live‑cell analysis platform company (MEA & imaging) spun out of Georgia Tech and widely used in neuroscience, cardiology, oncology, and virology research.\",\n      website: \"https://axionbiosystems.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Julien Bradley\",\n        \"role\": \"CEO\",\n        \"linkedin\": \"https://www.linkedin.com/in/julienbradley/\"\n      }\n    ],\n      recentNews: \"Acquired by Summa Equity in 2021; raised ~$20M including support via GRA Venture Fund.\"\n    },\n    {\n      id: \"radyus\",\n      name: \"Radyus Research\",\n      type: \"serviceProvider\",\n      size: 13,\n      description: \"Boutique preclinical CRO providing grant writing and project management services to startups.\",\n      website: \"https://radyusresearch.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Marta New\",\n        \"linkedin\": \"https://www.linkedin.com/in/melarnew/\"\n      },\n      {\n        \"name\": \"Kamyra Edokpolor\",\n        \"linkedin\": \"https://www.linkedin.com/in/kamyra-edokpolor/\"\n      },\n      {\n        \"name\": \"Benjamin Siciliano\",\n        \"linkedin\": \"https://www.linkedin.com/in/benjamin-siciliano/\"\n      },\n      {\n        \"name\": \"Anthony Chilton\",\n        \"linkedin\": \"https://www.linkedin.com/in/anthony-chilton-1994298/\"\n      },\n      {\n        \"name\": \"Caitlin J. Couch\",\n        \"linkedin\": \"https://www.linkedin.com/in/catecouch/\"\n      },\n      {\n        \"name\": \"Dave Edwards\",\n        \"linkedin\": \"https://www.linkedin.com/in/dave-edwards-a3a736b/\"\n      }\n    ],\n      recentNews: \"Announced strategic partnerships with Eurofins CDMO Alphora (May 2025) and Dt&CRO (May 2024) to deliver integrated drug development services.\"\n    },\n    {\n      id: \"tempus\",\n      name: \"Tempus\",\n      type: \"serviceProvider\",\n      size: 17,\n      description: \"Chicago-based precision medicine company with Atlanta genomics lab (acquired from AKESOgen in 2019). Maintains significant local operations and clinical partnerships but not Atlanta-founded.\",\n      website: \"https://www.tempus.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Maria Mikkelson\",\n        \"linkedin\": \"https://www.linkedin.com/in/maria-mikkelson-1b97b784/\"\n      },\n      {\n        \"name\": \"Christoff Coetzee\",\n        \"linkedin\": \"https://www.linkedin.com/in/christoff-coetzee-7673291/\"\n      }\n    ],\n      recentNews: \"Acquired AKESOgen in 2019; maintains Atlanta operations as part of its national genomics infrastructure for precision medicine and clinical trials.\"\n    },\n\n\n    {\n      id: \"biotechexec\",\n      name: \"BiotechExec\",\n      type: \"serviceProvider\",\n      size: 10,\n      description: \"Boutique consulting firm focused on biotech and medtech startups. Provides interim executive leadership, commercialization strategy, and capital planning support.\",\n      website: \"https://biotechexec.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Russell Allen\",\n        \"linkedin\": \"https://www.linkedin.com/in/rallen/\"\n      },\n      {\n        \"name\": \"William Dull\",\n        \"linkedin\": \"https://www.linkedin.com/in/william-dull/\"\n      }\n    ],\n      recentNews: \"Supports startups emerging from academic accelerators and translational research programs.\"\n    },\n\n\n    {\n      id: \"iqvia_atlanta\",\n      name: \"IQVIA\",\n      type: \"serviceProvider\",\n      size: 15,\n      description: \"Global CRO with Atlanta office providing clinical trial services and CDC partnerships\",\n      website: \"https://iqvia.com\",\n      keyPersonnel: [],\n      recentNews: \"Partnerships with CDC on real-world data\"\n    },\n    {\n      id: \"peachtree_bio\",\n      name: \"Peachtree BioResearch Solutions\",\n      type: \"serviceProvider\",\n      size: 11,\n      description: \"Full-service CRO based in Atlanta, clinical trial support\",\n      website: \"https://peachtreebrs.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Kristy Nichols\",\n          \"linkedin\": \"https://www.linkedin.com/in/kristy-nichols-85068410/\"\n        }\n      ],\n      recentNews: \"Regional clinical trial services\"\n    },\n    {\n      id: \"woven_health_collective\",\n      name: \"Woven Health Collective\",\n      type: \"serviceProvider\",\n      size: 13,\n      description: \"Healthcare commercialization consultancy formerly known as 11TEN Innovation Partners. Offers co-design, real-world piloting, and strategic support via its Innovation Lab in Atlanta.\",\n      website: \"https://wovenhealth.io\",\n      keyPersonnel: [\n      {\n        \"name\": \"James Lewis\",\n        \"linkedin\": \"https://www.linkedin.com/in/jamesrlewis2/\"\n      },\n      {\n        \"name\": \"Caleb Szubski\",\n        \"linkedin\": \"https://www.linkedin.com/in/calebrs/\"\n      },\n      {\n        \"name\": \"Steve Gertz\",\n        \"linkedin\": \"https://www.linkedin.com/in/steve-gertz-bb0a3721/\"\n      }\n    ],\n      recentNews: \"Rebranded to Woven Health Collective after ClinicalMind acquisition (2024). Continues as Emory Healthcare Innovation Hub partner.\"\n    },\n\n\n\n    {\n      id: \"vizzia\",\n      name: \"Vizzia Technologies\",\n      type: \"serviceProvider\",\n      size: 14,\n      description: \"Atlanta-based provider of real-time location systems (RTLS) and environmental monitoring software for hospitals. Selected by CHOA, Grady, and Piedmont to support Georgia's largest healthcare construction projects.\",\n      website: \"https://www.vizziatech.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Dave Wiedman\",\n        \"linkedin\": \"https://www.linkedin.com/in/dave-wiedman-b821881/\"\n      }\n    ],\n      recentNews: \"2025: RTLS selected for CHOA Blank Hospital; deployments at Piedmont's Marcus Tower and Grady's Correll Pavilion.\"\n    },\n    {\n      id: \"jones_day\",\n      name: \"Jones Day\",\n      type: \"serviceProvider\",\n      size: 12,\n      description: \"Global law firm with an established Atlanta office; active in life sciences, medtech, M&A, cross-border and VC transaction support for startups and growth companies.\",\n      website: \"https://www.jonesday.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Bill Zawrotny\",\n        \"linkedin\": \"https://www.linkedin.com/in/bill-zawrotny-19456b9/\"\n      },\n      {\n        \"name\": \"Katie Vest\",\n        \"linkedin\": \"https://www.linkedin.com/in/katievest/\"\n      }\n          ],\n      recentNews: \"Hosts legal educational series 'Brewed & Briefed' in Atlanta. Bill and Katie provide counsel to Georgia life sciences startups and investors.\"\n    },\n    {\n      id: \"bonnefire_atl\",\n      name: \"Bonne Fire ATL\",\n      type: \"community\",\n      size: 12,\n      description: \"Grassroots founder and funder gathering focused on early-stage healthtech, biotech, and digital health in Atlanta. Builds trust-based connections across investors, operators, and domain experts.\",\n      website: \"https://www.linkedin.com/company/bonnefireatl/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Nadine Peever\",\n        \"role\": \"Co-Founder\",\n        \"linkedin\": \"https://www.linkedin.com/in/nadinepeever/\"\n      },\n      {\n        \"name\": \"Alexa Morse\",\n        \"role\": \"Advisor & Co-Founder\",\n        \"linkedin\": \"https://www.linkedin.com/in/alexa-morse/\"\n      },\n      {\n        \"name\": \"Sarah Carrigan\",\n        \"role\": \"Public Health Engagement Chair\",\n        \"linkedin\": \"https://www.linkedin.com/in/sarahdavid413/\"\n      },\n      {\n        \"name\": \"Eddie Lai\",\n        \"role\": \"Advisor\",\n        \"linkedin\": \"https://www.linkedin.com/in/edwarddlai/\"\n      },\n      {\n        \"name\": \"Patrick Kennedy\",\n        \"role\": \"Host Team Member\",\n        \"linkedin\": \"https://www.linkedin.com/in/patrick-kennedy-b7919a59/\"\n      },\n      {\n        \"name\": \"Ben Huffman\",\n        \"role\": \"Host Team Member\",\n        \"linkedin\": \"https://www.linkedin.com/in/ben-1-huffman/\"\n      }\n    ],\n      recentNews: \"Hosted monthly pitch and networking events in 2024–2025 featuring emerging Atlanta healthtech startups.\"\n    },\n    {\n      id: \"agetech_connect\",\n      name: \"AgeTech Connect\",\n      type: \"community\",\n      size: 11,\n      description: \"Ecosystem convener focused on aging innovation, including gerotech, value-based care, and aging-in-place startups. Connects innovators with payers, providers, and public health programs.\",\n      website: \"https://www.agetechconnect.com\",\n      keyPersonnel: [],\n      recentNews: \"Launched regional events connecting age-related innovators to pilot partners and investors.\"\n    },\n\n    {\n      id: \"emory_biotech_consulting_club\",\n      name: \"EBCC\",\n      type: \"community\",\n      size: 11,\n      description: \"Student-led biotech consulting organization supporting Atlanta-area faculty inventors and startups with commercialization strategy. EBCC provides teams of graduate students from Emory, Georgia Tech, and Georgia State to perform market research, IP strategy, regulatory analysis, and customer discovery.\",\n      website: \"https://scholarblogs.emory.edu/ebcc/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Bill Wuest\",\n        \"linkedin\": \"https://www.linkedin.com/in/bill-wuest-7452063/\"\n      }\n    ],\n      recentNews: \"Since launching in 2019 under the Innovate@Emory initiative, EBCC has completed 50+ startup projects with partners including Biolocity, Emory OTT, GRA, and Emory Advancement.\"\n    },\n\n    // EMERGING STARTUPS\n    {\n      id: \"moonlight\",\n      name: \"Moonlight Therapeutics\",\n      type: \"startup\",\n      size: 10,\n      description: \"Developing a microneedle-based immunotherapy platform (TASIS) for food allergies. Portal Innovations' first Atlanta investment. Advancing lead program into Phase I trials.\",\n      website: \"https://moonlighttx.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Samir Patel\",\n        \"linkedin\": \"https://www.linkedin.com/in/patelsamirkumar/\"\n      }\n    ],\n      recentNews: \"Received multi-million dollar NIH Fast-Track grant for Phase I trial of MOON101 (peanut allergy immunotherapy), and raised Series A led by Portal Innovations.\"\n    },\n    {\n      id: \"andson_biotech\",\n      name: \"Andson Biotech\",\n      type: \"startup\",\n      size: 13,\n      description: \"Georgia Tech spinout building the DynaChip™ X1 platform to automate and miniaturize mass spectrometry sample prep for biologics and advanced therapeutics. Enables faster, cheaper, and more scalable bioanalysis.\",\n      website: \"http://www.andsonbiotech.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Mason Chilmonczyk\",\n        \"role\": \"CEO & Co‑Founder\",\n        \"linkedin\": \"https://www.linkedin.com/in/mason-chil/\"\n      }\n    ],\n      recentNews: \"Closed $3.6M seed funding round to accelerate launch of DynaChip mass spec sample prep solution.\"\n    },\n    {\n      id: \"sanguina\",\n      name: \"Sanguina\",\n      type: \"startup\",\n      size: 11,\n      description: \"Digital health startup spun out of Emory/GT collaboration. Developed AnemoCheck Mobile, a non-invasive app for anemia screening.\",\n      website: \"https://sanguina.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Erika Tyburski\",\n        \"linkedin\": \"https://www.linkedin.com/in/erika-tyburski-292555b1/\"\n      }\n    ],\n      recentNews: \"Received FDA clearance for AnemoCheck Home hemoglobin test kit for at-home anemia screening.\"\n    },\n    {\n      id: \"oxos\",\n      name: \"OXOS Medical\",\n      type: \"startup\",\n      size: 12,\n      description: \"Georgia Tech CREATE-X alumnus making portable, handheld X-ray imaging systems.\",\n      website: \"https://oxos.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Greg Kolovich\",\n        \"linkedin\": \"https://www.linkedin.com/in/gregory-kolovich-777900117/\"\n      },\n      {\n        \"name\": \"Evan Ruff\",\n        \"linkedin\": \"https://www.linkedin.com/in/evan-ruff/\"\n      }\n    ],\n      recentNews: \"Achieved FDA clearance for MC2 ultraportable x-ray system, expanding the handheld Micro C platform.\"\n    },\n    {\n      id: \"altesa\",\n      name: \"Altesa BioSciences\",\n      type: \"startup\",\n      size: 12,\n      description: \"Antiviral company formed in partnership with Emory's DRIVE institute to develop treatments for respiratory viruses.\",\n      website: \"https://altesabio.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"George Painter\",\n        \"linkedin\": \"https://www.linkedin.com/in/george-painter-61ab25126/\"\n      },\n      {\n        \"name\": \"Dennis Liotta\",\n        \"linkedin\": \"https://www.linkedin.com/in/dennis-liotta-1b087729/\"\n      }\n    ],\n      recentNews: \"Secured exclusive worldwide license from Vaxart for Vapendavir to treat RNA virus infections.\"\n    },\n    {\n      id: \"braintrust\",\n      name: \"BrainTrust Bio\",\n      type: \"startup\",\n      size: 10,\n      description: \"Emory spinout founded by neurosurgeon Dr. Nicholas Boulis, focusing on novel drug delivery methods for the central nervous system.\",\n      website: \"https://braintrustbio.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Chen Benkler\",\n        \"linkedin\": \"https://www.linkedin.com/in/chen-benkler/\"\n      },\n      {\n        \"name\": \"Nicholas Boulis\",\n        \"linkedin\": \"https://www.linkedin.com/in/nicholas-boulis-73124b39/\"\n      }\n    ],\n      recentNews: \"Received approval for Phase I trial of continuous intrathecal drug delivery targeting CNS diseases.\"\n    },\n    {\n      id: \"synaptrix\",\n      name: \"Synaptrix\",\n      type: \"startup\",\n      size: 10,\n      description: \"Atlanta-based startup developing a non-invasive, drug-free pain management system (NOVABLOC™) for post-operative knee pain. Clinical-stage therapy delivering novel electrical stimulation to extend pain relief while preserving sensory function.\",\n      website: \"https://www.linkedin.com/company/novabloc-pain-free-knee/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Shyamy Sastry\",\n        \"linkedin\": \"https://www.linkedin.com/in/shyamy-sastry-4508922/\"\n      }\n    ],\n      recentNews: \"Raised $10M Series A round with Portal Innovations as investor to advance NOVABLOC pain management system.\"\n    },\n\n    {\n      id: \"avanos\",\n      name: \"Avanos\",\n      type: \"company\",\n      size: 14,\n      description: \"Medtech company headquartered in Alpharetta, GA. Focuses on chronic care and pain management solutions, including nerve block and respiratory health technologies.\",\n      website: \"https://avanos.com\",\n      keyPersonnel: [],\n      recentNews: \"Serves as the origin for Synaptrix technology via spinout.\"\n    },\n    {\n      id: \"drive\",\n      name: \"DRIVE\",\n      type: \"incubator\",\n      size: 13,\n      description: \"Non-profit bioventure entity established by Emory to accelerate the development of antiviral therapeutics. Operates with an entrepreneurial biotech model to translate early-stage discoveries into global treatments.\",\n      website: \"https://driveinnovations.org/\",\n      keyPersonnel: [],\n      recentNews: \"Enabled the development and licensing of molnupiravir (Lagevrio) to Merck. Supports Emory antiviral drug discovery efforts.\"\n    },\n    {\n      id: \"ebfi\",\n      name: \"EBFI\",\n      type: \"incubator\",\n      size: 12,\n      description: \"Venture support institute based at Emory. Identifies and supports high-potential life science innovations with investment, mentorship, and commercialization strategy to bridge academia and industry.\",\n      website: \"https://www.ebfi.org/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Michael Tanenbaum\",\n        \"linkedin\": \"https://www.linkedin.com/in/michael-tanenbaum-447a54b/\"\n      },\n      {\n        \"name\": \"Nassir Mokarram\",\n        \"linkedin\": \"https://www.linkedin.com/in/nassir-mokarram-5b966017/\"\n      }\n    ],\n      recentNews: \"Supports Emory-affiliated startups across medtech, diagnostics, and therapeutics.\"\n    },\n    {\n      id: \"eddf\",\n      name: \"EDDF\",\n      type: \"vc\",\n      size: 12,\n      description: \"Early-stage investment fund under Emory Innovations, Inc. Established in 2023 using royalties from Merck's LEGEVRIO™ (molnupiravir). Funds Emory-discovered therapeutics to IND/clinical milestones.\",\n      website: \"https://innovate.emory.edu/ecosystem/emory-drug-development-fund.html\",\n      keyPersonnel: [\n      {\n        \"name\": \"Doug Gooding\",\n        \"linkedin\": \"https://www.linkedin.com/in/doug-gooding-75248967/\"\n      }\n    ],\n      recentNews: \"Backed Emory-based projects in IBD, seizure disorders, and respiratory disease.\"\n    },\n    {\n      id: \"allonix\",\n      name: \"Allonix\",\n      type: \"startup\",\n      size: 10,\n      description: \"Emory spinout developing small molecule agonists targeting inflammation and cholesterol pathways for the treatment of inflammatory bowel disease (IBD). Co-founded with Orange Grove Bio.\",\n      website: \"https://gra.org/company/324/Allonix.html\",\n      keyPersonnel: [\n      {\n        \"name\": \"Eric Ortlund\",\n        \"linkedin\": \"https://www.linkedin.com/in/eric-ortlund-31600611/\"\n      }\n    ],\n      recentNews: \"EDDF portfolio company focused on IBD therapeutics.\"\n    },\n    {\n      id: \"agrithera\",\n      name: \"AgriThera\",\n      type: \"startup\",\n      size: 10,\n      description: \"Emory spinout developing cannabinoid pro-drug therapeutics for seizure disorders, chronic pain, and anxiety.\",\n      website: \"https://agrithera.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Dennis Liotta\",\n        \"linkedin\": \"https://www.linkedin.com/in/dennis-liotta-1b087729/\"\n      },\n      {\n        \"name\": \"Stephen Traynelis\",\n        \"linkedin\": \"https://www.linkedin.com/in/stephen-traynelis-22726ab/\"\n      }\n    ],\n      recentNews: \"Part of EDDF portfolio targeting neurotherapeutics.\"\n    },\n    {\n      id: \"cambium_oncology\",\n      name: \"Cambium\",\n      type: \"startup\",\n      size: 13,\n      description: \"Immuno‑oncology startup headquartered in Atlanta, GA developing first‑in‑class VIP receptor antagonists (e.g. ANT308) to restore anti‑cancer T‑cell activity in tumors with elevated VIP/VPAC signaling.\",\n      website: \"https://cambiumoncology.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Ned Waller\",\n        \"linkedin\": \"https://www.linkedin.com/in/edmundwaller/\"\n      },\n      {\n        \"name\": \"Gary Altman\",\n        \"linkedin\": \"https://www.linkedin.com/in/ggaltman/\"\n      }\n    ],\n      recentNews: \"Secured $5M equity investment from OEP Innovations and awarded NIH Fast-Track grant to advance lead anti-cancer candidate ANT308 to IND\"\n    },\n    {\n      id: \"switchboard_md\",\n      name: \"Switchboard, MD\",\n      type: \"startup\",\n      size: 12,\n      description: \"Atlanta-based digital health startup using physician-built AI to streamline care team workflows. Offers solutions for inbox management, disease escalation, and revenue cycle through real-time prioritization and routing of clinical and admin tasks.\",\n      website: \"https://www.switchboardmd.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Blake Anderson, MD\",\n        \"linkedin\": \"https://www.linkedin.com/in/blake-anderson-md-176339a2/\"\n      },\n      {\n        \"name\": \"Bradley Gallaher\",\n        \"linkedin\": \"https://www.linkedin.com/in/bradleygallaher/\"\n      },\n      {\n        \"name\": \"Ankit Tiwari\",\n        \"linkedin\": \"https://www.linkedin.com/in/ankitrtiwari/\"\n      },\n      {\n        \"name\": \"Will Akers\",\n        \"linkedin\": \"https://www.linkedin.com/in/williamakers1177/\"\n      },\n      {\n        \"name\": \"Kelly Luckasevic\",\n        \"linkedin\": \"https://www.linkedin.com/in/kellyluckasevic/\"\n      },\n      {\n        \"name\": \"Ashley Badgett\",\n        \"linkedin\": \"https://www.linkedin.com/in/ashley-badgett/\"\n      },\n      {\n        \"name\": \"Yuanda Zhu, PhD\",\n        \"linkedin\": \"https://www.linkedin.com/in/yuanda-zhu/\"\n      }\n    ],\n      recentNews: \"Surpassed 100 provider clients with AI-driven care team workflow platform; Emory Health pilot expands.\"\n    },\n    {\n      id: \"armor_medical\",\n      name: \"Armor Medical\",\n      type: \"startup\",\n      size: 10,\n      description: \"Atlanta-based medtech startup developing Maternal aRMOR, a wearable for early detection of postpartum hemorrhage.\",\n      website: \"https://armormedical.us\",\n      keyPersonnel: [],\n      recentNews: \"Selected for MedTech Innovator 2025 global showcase; received investment from Catalyst by Wellstar\"\n    },\n    {\n      id: \"rimidi\",\n      name: \"Rimidi\",\n      type: \"startup\",\n      size: 12,\n      description: \"Atlanta-based digital health company offering software platforms for chronic disease management, patient engagement, and clinical decision support. Works with health systems to integrate into EHRs and personalize patient treatment.\",\n      website: \"https://rimidi.com\",\n      keyPersonnel: [\n      {\n        \"name\": \"Lucienne Ide\",\n        \"linkedin\": \"https://www.linkedin.com/in/lucienneide/\"\n      }\n    ],\n      recentNews: \"Partnered with Emory Healthcare to deploy digital treatment platforms and remote monitoring for chronic disease.\"\n    },\n    {\n      id: \"metaclipse\",\n      name: \"Metaclipse Therapeutics\",\n      type: \"startup\",\n      size: 10,\n      description: \"Atlanta-based immuno-oncology startup developing virus-like particle (VLP)-based personalized cancer vaccines using patient tumor neoantigen profiling and AI-powered peptide selection. Founded by Georgia Tech researchers with Emory-affiliated scientific advisors.\",\n      website: \"https://metaclipse.com/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Hemanth Singuluri\",\n        \"linkedin\": \"https://www.linkedin.com/in/hemanth-singuluri/\"\n      },\n      {\n        \"name\": \"Sampath Ramachandiran\",\n        \"linkedin\": \"https://www.linkedin.com/in/sampath-ramachandiran-714ab918/\"\n      }\n    ],\n      recentNews: \"Emerging from stealth in 2024 with preclinical data on personalized VLP vaccine platform targeting solid tumors; affiliated with Georgia Tech and backed by seed-stage venture capital.\"\n    },\n    {\n      id: \"allai_health\",\n      name: \"Allai Health\",\n      type: \"startup\",\n      size: 10,\n      description: \"Atlanta-based AI-enabled precision medicine startup focused on genomics, early detection, and personalized health insights. Uses multimodal patient data to identify disease risk and improve outcomes.\",\n      website: \"https://allaihealth.com/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Mark Bouzyk\",\n        \"linkedin\": \"https://www.linkedin.com/in/mark-b-8a42648/\"\n      }\n    ],\n      recentNews: \"Launched in 2023 by serial genomics entrepreneur Mark Bouzyk. Builds upon clinical genomics platforms developed through AKESOgen and other ventures.\"\n    },\n    {\n      id: \"nucleate_atlanta\",\n      name: \"Nucleate\",\n      type: \"community\",\n      size: 12,\n      description: \"Nonprofit organization accelerating the next generation of biotech founders from academia. Nucleate Atlanta chapter supports PhD and postdoc-led venture teams at Emory, Georgia Tech, and Morehouse through structured mentorship and company formation programs.\",\n      website: \"https://nucleate.org/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Daniel Aziz\",\n        \"linkedin\": \"https://www.linkedin.com/in/danielaziz298461138/\"\n      },\n      {\n        \"name\": \"Sean Healy\",\n        \"linkedin\": \"https://www.linkedin.com/in/sean-healy-53202b18b/\"\n      },\n      {\n        \"name\": \"Hung-Jen Wu\",\n        \"linkedin\": \"https://www.linkedin.com/in/hungjenwu/\"\n      }\n    ],\n      recentNews: \"Launched Atlanta chapter in 2023. Supports cohorts of academic biotech teams with support from national partners like BMS, RA Capital, and Y Combinator Bio.\"\n    },\n    {\n      id: \"tamm_net\",\n      name: \"TAMM Net\",\n      type: \"serviceProvider\",\n      size: 12,\n      description: \"Atlanta-based strategic consulting firm specializing in regulatory strategy, market access, and commercialization planning for life sciences and digital health startups. Active partner in healthtech innovation and product launch strategy.\",\n      website: \"https://www.tammnet.com/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Art Spalding\",\n        \"linkedin\": \"https://www.linkedin.com/in/artspalding/\"\n      },\n      {\n        \"name\": \"Betty Lou Anderson\",\n        \"linkedin\": \"https://www.linkedin.com/in/bettylouanderson/\"\n      }\n    ],\n      recentNews: \"Supports early-stage and growth healthtech firms in navigating regulatory and commercial milestones; frequently involved in regional biotech events and venture readiness programs.\"\n    },\n    {\n      id: \"exvade_bioscience\",\n      name: \"Exvade Bioscience\",\n      type: \"startup\",\n      size: 11,\n      description: \"Atlanta-based medtech startup developing the Tumor Monorail device for guiding glioblastoma cells into a retrievable reservoir, enabling serial biopsy and real‑time monitoring.\",\n      website: \"https://www.exvadebio.com/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Nassir Mokarram, PhD\",\n        \"linkedin\": \"https://www.linkedin.com/in/nassir-mokarram-5b966017/\"\n      },\n      {\n        \"name\": \"Sean Meehan\",\n        \"linkedin\": \"https://www.linkedin.com/in/sean-meehan-93799215/\"\n      },\n      {\n        \"name\": \"Barun Brahma, MD\",\n        \"linkedin\": \"https://www.linkedin.com/in/barun-brahma-b5b9247/\"\n      }\n    ],\n      recentNews: \"Awarded NIH Fast‑Track Phase I/II SBIR in 2024. First‑in‑human trials initiated for GBM device in partnership with academic medical centers.\"\n    },\n    {\n      id: \"oncurna\",\n      name: \"OnCuRNA\",\n      type: \"startup\",\n      size: 11,\n      description: \"Georgia Tech/Biolocity-supported biotech startup developing nanostructured RNAi delivery platforms (SANGs) targeting solid tumors, including ovarian and other high‑need cancers.\",\n      website: \"https://oncurna.com/\",\n      keyPersonnel: [\n      {\n        \"name\": \"Nick Housley, PhD\",\n        \"linkedin\": \"https://www.linkedin.com/in/nick-housley/\"\n      }\n    ],\n      recentNews: \"Selected in 2025‑26 Biolocity cohort for ovarian cancer drug delivery platform – receiving mentorship and non‑dilutive funding.\"\n    },\n    {\n      id: \"huxley_medical\",\n      name: \"Huxley Medical\",\n      type: \"startup\",\n      size: 7,\n      description: \"Atlanta‑based medical device company developing multi‑sensor diagnostic patch (SANSA) for cardio‑sleep and vital sign monitoring.\",\n      website: \"https://www.huxleymed.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Chris Lee\",\n          \"linkedin\": \"https://www.linkedin.com/in/chris-lee-20995922/\"\n        }\n      ],\n      recentNews: \"Completed first feasibility study of SANSA cardio-sleep patch with Emory & CHOA in June 2025.\"\n    },\n    {\n      \"id\": \"biocircuit_technologies\",\n      \"name\": \"BioCircuit Technologies\",\n      \"type\": \"startup\",\n      \"size\": 8,\n      \"description\": \"Atlanta‑based bioelectronics startup developing Nerve Tape®—a sutureless nerve repair patch backed by NIH SBIR and GRA Venture Fund support.\",\n      \"website\": \"https://www.biocircuit.com/\",\n      \"keyPersonnel\": [],\n      \"recentNews\": \"NIH awarded $3M SBIR to expand Nerve Tape; GRA Venture Fund backed company through early-stage investment.\"\n    },\n    {\n      id: \"synthbiome\",\n      name: \"SynthBiome\",\n      type: \"startup\",\n      size: 10,\n      description: \"Atlanta-based biotechnology company developing synthetic environments to mimic physiological conditions for drug development and treatment selection. Focuses on creating accurate synthetic models for cystic fibrosis research (SCFM1, SCFM2) and chronic wound infection research (LCWB).\",\n      website: \"https://www.synthbiome.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Marvin Whiteley\",\n          \"linkedin\": \"https://www.linkedin.com/in/marvin-whiteley-895997194/\"\n        }\n      ],\n      recentNews: \"Founded in 2022. Developing synthetic media that accurately replicate human infection environments for improved drug development and antibiotic treatment selection.\"\n    },\n    {\n      id: \"tether_therapeutics\",\n      name: \"Tether Therapeutics\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based mRNA therapeutics company developing inhalable treatments for life-threatening respiratory diseases using proprietary polymer formulations. Technology based on novel chemistry developed at Georgia Tech and Emory University, optimized for lung delivery.\",\n      website: \"https://tethertx.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Michael Chang\",\n          \"linkedin\": \"https://www.linkedin.com/in/michaelcchang2/\"\n        }\n      ],\n      recentNews: \"Developing next-generation gene therapy for respiratory disease using biodegradable polymeric nanoparticles for aerosol gene delivery.\"\n    },\n    {\n      id: \"dr_noze_best\",\n      name: \"Dr. Noze Best\",\n      type: \"company\",\n      size: 10,\n      description: \"Atlanta-based pediatric health and wellness company founded by Pediatric ENT Dr. Steven Goudy. Develops innovative wellness solutions that improve children's health and reduce stress for parents. Best known for the NozeBot electric nasal aspirator - a physician-founded, hospital-level quality device for pediatric nasal congestion relief.\",\n      website: \"https://drnozebest.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Dr. Steven Goudy, MD, MBA\",\n          \"linkedin\": \"https://www.linkedin.com/in/steven-goudy-md-mba-b3ba819/\"\n        },\n        {\n          \"name\": \"Christy Brown\",\n          \"linkedin\": \"https://www.linkedin.com/in/christy-brown-a54aa0/\"\n        }\n      ],\n      recentNews: \"Founded in 2016 by Pediatric ENT Dr. Steven Goudy. Products include NozeBot electric nasal aspirator, NozeBot On the Go, and BreatheEZ humidifier. Featured in Forbes, Parents.com, and other major publications. ATDC-funded company.\"\n    },\n    {\n      id: \"codoxo\",\n      name: \"Codoxo\",\n      type: \"serviceProvider\",\n      size: 16,\n      description: \"Atlanta-based healthcare technology company (formerly Fraudscope) developing AI-powered payment integrity and fraud detection solutions. Uses patented Forensic AI Platform with generative AI to identify healthcare fraud, waste, and abuse earlier than traditional methods. Helps healthcare payers, PBMs, and government agencies reduce costs and ensure healthcare dollars go to real patient care.\",\n      website: \"https://www.codoxo.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Musheer Ahmed\",\n          \"linkedin\": \"https://www.linkedin.com/in/musheerahmed/\"\n        }\n      ],\n      recentNews: \"Named to Inc. 5000 Fastest Growing Companies. CEO Musheer Ahmed recognized in Atlanta Business Chronicle's 40 Under 40. Forensic AI Platform named Fierce Healthcare Innovation Award winner. Serves over 80 million lives across healthcare payers, PBMs, and government agencies.\"\n    },\n    {\n      id: \"youngheartvalve\",\n      name: \"YoungHeartValve\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based cardiovascular medtech startup developing next-generation heart valve technology. Creates hyaluronan-enhanced, polymeric transcatheter aortic valves that eliminate the need for animal tissue and anticoagulants.\",\n      website: \"https://youngheartvalve.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Prasad Dasi\",\n          \"linkedin\": \"https://www.linkedin.com/in/lakshmi-dasi-2613659/\"\n        },\n        {\n          \"name\": \"Todd Tomba\",\n          \"linkedin\": \"https://www.linkedin.com/in/toddtomba/\"\n        }\n      ],\n      recentNews: \"Successfully raised $450K+ in NIH SBIR Phase 1 funding (double the normal amount). Located at T3 Labs in Global Center for Medical Innovation, Atlanta.\"\n    },\n    {\n      id: \"oz_link_technologies\",\n      name: \"OZ-Link Technologies\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based biotechnology company developing a family of self-cleaving chemical linkers for controlled release therapeutics. Enables exquisite control of therapeutic detachment from any carrier at pre-programmed rates ranging from minutes to weeks.\",\n      website: \"https://www.ozlinktech.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Dr. Kasie Collins\",\n          \"linkedin\": \"https://www.linkedin.com/in/kasielcollins/\"\n        }\n      ],\n      recentNews: \"Founded in 2022. Developing modular platform for time-controlled release from small molecules to biologics and vaccines, improving pharmacokinetics and minimizing off-target effects.\"\n    },\n    {\n      id: \"lymphatech\",\n      name: \"LymphaTech\",\n      type: \"startup\",\n      size: 10,\n      description: \"Atlanta-based healthcare technology company focused on innovative 3D measurement solutions for clinical care. Digital measuring platform with proprietary algorithms for accurate human geometry measurement, serving physical therapists, oncology, and compression garment professionals.\",\n      website: \"https://www.lymphatechnology.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Mike Weiler\",\n          \"linkedin\": \"https://www.linkedin.com/in/mike-weiler-8725a130/\"\n        },\n        {\n          \"name\": \"J. Brandon Dixon\",\n          \"linkedin\": \"https://www.linkedin.com/in/jbrandondixon/\"\n        },\n        {\n          \"name\": \"Nathan Frank\",\n          \"linkedin\": \"https://www.linkedin.com/in/nathan-frank-7881597/\"\n        }\n      ],\n      recentNews: \"Founded in 2014. Received seed funding from Georgia Research Alliance in 2015. System is 99% accurate compared to water displacement for volume and tape measure for circumference, validated through external clinical research.\"\n    },\n    {\n      id: \"jackson_medical\",\n      name: \"Jackson Medical\",\n      type: \"startup\",\n      size: 12,\n      description: \"Atlanta-based safety-focused medical and surgical device company. Manufactures GloShield™, a fiber-optic light cable shield that reduces potential for fires and burns to patients and hospital staff during surgeries.\",\n      website: \"https://www.jackson-medical.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"James Rains\",\n          \"linkedin\": \"https://www.linkedin.com/in/jamesrains/\"\n        },\n        {\n          \"name\": \"Kamil Makhnejia\",\n          \"linkedin\": \"https://www.linkedin.com/in/kamilmakhnejia/\"\n        },\n        {\n          \"name\": \"Spencer Kozinn\",\n          \"linkedin\": \"https://www.linkedin.com/in/spencer-kozinn-a18617b6/\"\n        }\n      ],\n      recentNews: \"GloShield™ has been used in over 250,000 surgeries with zero burns. Award-winning solution that aligns with Joint Commission and AORN recommendations for surgical fire prevention.\"\n    },\n    {\n      id: \"ethos_medical\",\n      name: \"Ethos Medical\",\n      type: \"startup\",\n      size: 8,\n      description: \"Atlanta-based medical device company developing the Iris needle guidance system for safer and more efficient percutaneous access. Interfaces with existing ultrasound equipment to enable dynamic image guidance with pre-puncture needle path prediction.\",\n      website: \"https://www.ethos-medical.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Cassidy Wang\",\n          \"linkedin\": \"https://www.linkedin.com/in/cassidywang/\"\n        },\n        {\n          \"name\": \"Lucas Mara Muller\",\n          \"linkedin\": \"https://www.linkedin.com/in/lucas-mara-muller/\"\n        }\n      ],\n      recentNews: \"Founded in 2018. Supported by National Science Foundation funding. Member of Portal Innovations at Science Square. Developing real-time instrument guidance for safer and simpler spinal access.\"\n    },\n    {\n      id: \"veranex\",\n      name: \"Veranex\",\n      type: \"serviceProvider\",\n      size: 16,\n      description: \"Innovation CRO providing comprehensive medical device and diagnostic development services from concept to commercialization. Acquired T3 Labs in 2024, expanding preclinical testing capabilities in Atlanta. Offers integrated services including design & development, preclinical research, clinical research, regulatory consulting, and commercialization support.\",\n      website: \"https://veranex.com\",\n      keyPersonnel: [],\n      recentNews: \"Acquired T3 Labs in 2024, expanding preclinical testing capabilities in Atlanta's Science Square. T3 Labs brings 33,000-square-foot facility with expertise in 12 therapeutic areas and over 60 FDA-approved products in the past decade.\"\n    },\n    {\n      id: \"lybbie\",\n      name: \"Lybbie\",\n      type: \"startup\",\n      size: 8,\n      description: \"Health technology company focused on solving overlooked challenges in early parenthood. Building tools that support breastfeeding through science, technology, and empathy — offering new ways to understand and optimize the feeding experience. Founded by Dr. Andrea Braden, a nationally recognized Ob/Gyn and expert in Breastfeeding Medicine.\",\n      website: \"https://www.lybbie.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Dr. Andrea Braden\",\n          \"linkedin\": \"https://www.linkedin.com/in/drandreabraden/\"\n        }\n      ],\n      recentNews: \"Founded in 2019. Built by physicians, informed by parents, backed by data. Developing patented continuous milk monitoring technology to address Perceived Insufficient Milk Syndrome affecting 87% of moms.\"\n    },\n    {\n      id: \"aruna_bio\",\n      name: \"Aruna Bio\",\n      type: \"company\",\n      size: 15,\n      description: \"Harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body's anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. Leveraging proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing exosomes with small molecules, RNA, oligonucleotides and antibodies.\",\n      website: \"https://www.arunabio.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Steven Stice\",\n          \"linkedin\": \"https://www.linkedin.com/in/steven-stice-337a048/\"\n        },\n        {\n          \"name\": \"Tracey Worthington Stice\",\n          \"linkedin\": \"https://www.linkedin.com/in/twstice/\"\n        }\n      ],\n      recentNews: \"Founded in 2003. Developing AB126, a therapeutic neural cell-derived exosome that demonstrates multiple modes of action: reducing neuro-inflammation, promoting neuro-protection, and stimulating neuro-regeneration.\"\n    },\n    {\n      id: \"accuitis\",\n      name: \"Accuitis Pharmaceuticals\",\n      type: \"company\",\n      size: 10,\n      description: \"Developing therapeutics which protect and restore healthy cellular function in neurodegenerative diseases. Participant in the Georgia Research Alliance Venture Lab program with key technology discovered by Emory University. Engaged in acquisition and development of pharmaceuticals targeting niche, orphan, and underserved disease states.\",\n      website: \"https://accuitis.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Rick Coulon\",\n          \"linkedin\": \"https://www.linkedin.com/in/rick-coulon-b7b2756/\"\n        },\n        {\n          \"name\": \"Jack Arbiser\",\n          \"linkedin\": \"https://www.linkedin.com/in/jack-arbiser-7119039/\"\n        },\n        {\n          \"name\": \"Mike Shippel\",\n          \"linkedin\": \"https://www.linkedin.com/in/mikeshippel/\"\n        },\n        {\n          \"name\": \"Adam Sabouni\",\n          \"linkedin\": \"https://www.linkedin.com/in/adamsabouni/\"\n        }\n      ],\n      recentNews: \"Founded in 2011. Lead compound AN-018 is a small molecule validated in preclinical research to restore mitochondrial SIRT3 expression for treating Alzheimer's, Parkinson's disease, and methamphetamine addiction.\"\n    },\n    {\n      id: \"diasyst\",\n      name: \"Diasyst\",\n      type: \"company\",\n      size: 15,\n      description: \"Introduces the first ever Medication Intelligence solution for chronic disease management, empowering healthcare providers to make timely, quick, safe, and effective treatment decisions. Backed by decades of research at Emory University and the VA, Diasyst gathers, computerizes, and maintains an ever-expanding knowledge base of clinical guidelines, drug labels, research studies, and best practices.\",\n      website: \"https://www.diasyst.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Chun Yong\",\n          \"linkedin\": \"https://www.linkedin.com/in/chunyong/\"\n        },\n        {\n          \"name\": \"Med LSP\",\n          \"linkedin\": \"https://www.linkedin.com/in/medlsp/\"\n        },\n        {\n          \"name\": \"Dimitar Ivanov\",\n          \"linkedin\": \"https://www.linkedin.com/in/dimitar-ivanov-16942a17/\"\n        }\n      ],\n      recentNews: \"Founded in 2015. Through proprietary AI, Diasyst delivers treatment recommendations to decision-makers, helping save time, increase revenues, and maximize patient outcomes. Received GRA funding in 2019.\"\n    },\n    {\n      id: \"earlitec\",\n      name: \"EarliTec Diagnostics\",\n      type: \"company\",\n      size: 15,\n      description: \"Making earlier identification and treatment for autism and related early childhood vulnerabilities accessible to children everywhere. EarliTec's flagship product, EarliPoint™, is FDA authorized to diagnose and assess autism in children ages 16-30 months old.\",\n      website: \"https://earlitecdx.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Cheryl Tierney\",\n          \"linkedin\": \"https://www.linkedin.com/in/cheryl-tierney-md-mph/\"\n        },\n        {\n          \"name\": \"Jonathan Lehmann\",\n          \"linkedin\": \"https://www.linkedin.com/in/jonathan-lehmann-0014ba25/\"\n        },\n        {\n          \"name\": \"John Revier\",\n          \"linkedin\": \"https://www.linkedin.com/in/john-reviere-3307973/\"\n        },\n        {\n          \"name\": \"Ryan Bormann\",\n          \"linkedin\": \"https://www.linkedin.com/in/ryan-bormann-5798955/\"\n        }\n      ],\n      recentNews: \"Founded in 2019. EarliPoint System device is FDA-authorized as a tool to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children ages 16 months through 30 months. Uses clinically validated measures to track social-visual engagement.\"\n    },\n    {\n      id: \"kodikaz\",\n      name: \"Kodikaz Therapeutics\",\n      type: \"startup\",\n      size: 8,\n      description: \"Developing targeted cancer therapies through their Zip-Code™ Technology platform, a first-in-class cell-specific delivery system for gene therapy applications. Derived from endogenous human mechanisms, avoiding viral delivery challenges while being universally applicable and cell-type specific.\",\n      website: \"https://kodikaz.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Anthony Johnson\",\n          \"linkedin\": \"https://www.linkedin.com/in/anjoso/\"\n        },\n        {\n          \"name\": \"Matthew Tindall\",\n          \"linkedin\": \"https://www.linkedin.com/in/matthewtindall/\"\n        }\n      ],\n      recentNews: \"Founded in 2018. Mission to move from incremental cancer therapies with devastating side effects to durable cures through targeted therapies that can eradicate cancers completely. Zip-Code™ Technology platform redefining boundaries of medicine for new therapeutic approaches.\"\n    },\n    {\n      id: \"nyra_medical\",\n      name: \"Nyra Medical\",\n      type: \"company\",\n      size: 15,\n      description: \"Clinical-stage medical company pioneering a new era in structural heart care. Mission to improve and extend the lives of patients with valvular heart disease through elegant, transcatheter solutions that restore valve function while preserving natural physiology.\",\n      website: \"https://nyramedical.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Lori Chmura\",\n          \"linkedin\": \"https://www.linkedin.com/in/lori-chmura-9938556/\"\n        },\n        {\n          \"name\": \"Murali Padala\",\n          \"linkedin\": \"https://www.linkedin.com/in/murali-padala-462a677/\"\n        },\n        {\n          \"name\": \"Adam Martinez\",\n          \"linkedin\": \"https://www.linkedin.com/in/adamwmartinez/\"\n        },\n        {\n          \"name\": \"Jennifer Mischke\",\n          \"linkedin\": \"https://www.linkedin.com/in/jennifermischke/\"\n        }\n      ],\n      recentNews: \"Founded in 2021. Proprietary Cardiac Leaflet Enhancer (CARLEN) technology designed to address unmet need through sutureless, single-leaflet device that augments native valve anatomy. Licensed core technology from Emory University in 2021, raised Series A in 2022.\"\n    },\n    {\n      id: \"metanoi\",\n      name: \"Metanoi Therapeutics\",\n      type: \"startup\",\n      size: 14,\n      description: \"Pioneering cancer treatment company developing non-toxic oral therapies that selectively destroy cancer cells while sparing healthy tissue. Novel mechanism exploits cancer cells' inefficient energy production by depleting glucose and glutamine and disrupting mitochondrial integrity.\",\n      website: \"https://www.metanoitherapeutics.com\",\n      keyPersonnel: [\n        {\n          \"name\": \"Guilherme Cantuaria\",\n          \"linkedin\": \"https://www.linkedin.com/in/guilherme-cantuaria-3bb27718b/\"\n        },\n        {\n          \"name\": \"Stephan Jackman\",\n          \"linkedin\": \"https://www.linkedin.com/in/stephan-jackman-4578328a/\"\n        },\n        {\n          \"name\": \"Brad Sullivan\",\n          \"linkedin\": \"https://www.linkedin.com/in/brad-sullivan-caia-cmt-45bbb36/\"\n        },\n        {\n          \"name\": \"Dan King\",\n          \"linkedin\": \"https://www.linkedin.com/in/dan-king-694601/\"\n        }\n      ],\n      recentNews: \"Developing VET001 for animals targeting INAD submission and MET001 for humans targeting IND submission for Phase I trials. Company focuses on broad efficacy across multiple cancers including prostate, breast, and colon.\"\n    },\n    {\n      id: \"alzamend\",\n      name: \"Alzamend Neuro\",\n      type: \"public_company\",\n      size: 16,\n      description: \"Clinical-stage biopharmaceutical company focused on developing novel treatments for Alzheimer's disease, Bipolar disorder, Major Depressive Disorder, and PTSD. Pipeline includes AL001 (ionic cocrystal technology) and ALZN002 (cell-based therapeutic vaccine).\",\n      website: \"https://alzamend.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Stephan Jackman\",\n          \"linkedin\": \"https://www.linkedin.com/in/stephan-jackman-4578328a/\"\n        },\n        {\n          \"name\": \"David Katzoff\",\n          \"linkedin\": \"https://www.linkedin.com/in/davidjkatzoff/\"\n        },\n        {\n          \"name\": \"Henry Nisser\",\n          \"linkedin\": \"https://www.linkedin.com/in/henry-nisser-900a3221/\"\n        },\n        {\n          \"name\": \"Ken Cragun\",\n          \"linkedin\": \"https://www.linkedin.com/in/kencragun/\"\n        }\n      ],\n      recentNews: \"NASDAQ-listed company (ALZN) currently dosing first patient in Phase II clinical trial of AL001 'Lithium in Brain' study at Massachusetts General Hospital. Successfully raised $5 million in private placement ahead of schedule.\"\n    },\n    {\n      id: \"arnav\",\n      name: \"ARNAV Biotech\",\n      type: \"company\",\n      size: 15,\n      description: \"mRNA manufacturing and contract research company offering high quality, custom and catalogued mRNA with expertise in mRNA design and optimization. Helps academic and industry scientists develop mRNA-based therapeutics and vaccines for therapeutic, vaccine, diagnostic and agricultural applications.\",\n      website: \"http://www.arnavbiotech.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Pooja Tiwari\",\n          \"linkedin\": \"https://www.linkedin.com/in/poojamtiwari/\"\n        }\n      ],\n      recentNews: \"Secured exclusive license for cutting-edge Anti-RSV inhibitor from Alabama State University. Entered collaboration with Sartorius BIA Separations to develop mRNA synthesis and purification platform with PATfix in-process analytical solution.\"\n    },\n    {\n      id: \"synthbiome\",\n      name: \"SynthBiome\",\n      type: \"startup\",\n      size: 14,\n      description: \"Designs synthetic environments to mimic physiological conditions that microorganisms encounter in their natural environments. Manufactures specialized growth media including synthetic media that imitate CF-sputum and chronic wound environments for better drug development and treatment selection.\",\n      website: \"https://www.synthbiome.com/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Marvin Whiteley\",\n          \"linkedin\": \"https://www.linkedin.com/in/marvin-whiteley-895997194/\"\n        }\n      ],\n      recentNews: \"Founded by Marvin Whiteley, PhD from Georgia Tech. Focuses on creating accurate synthetic models for drug development and treatment selection, moving beyond traditional clinical models to provide adaptive, scalable simulations of human physiology.\"\n    },\n    {\n      id: \"artpharmacy\",\n      name: \"Art Pharmacy\",\n      type: \"company\",\n      size: 16,\n      description: \"America's leader in healthcare-grade social prescribing, delivering evidence-based solutions for the dual mental health and loneliness epidemics. Enables personalized social prescribing services with healthcare, university, corporate, and government partners to address the nation's most intractable health challenges.\",\n      website: \"https://www.artpharmacy.co/\",\n      keyPersonnel: [\n        {\n          \"name\": \"Chris Appleton\",\n          \"linkedin\": \"https://www.linkedin.com/in/chris-appleton-atl/\"\n        }\n      ],\n      recentNews: \"Partners with major health systems including UnitedHealthcare, Stanford, Grady, Mass General Brigham, Emory, and Wellstar. Provides end-to-end social prescribing solutions for health plans, universities, and health systems to address mental health, social isolation, and loneliness.\"\n    }\n  ],\n\n  links: [\n    // --- Core Academic Collaborations ---\n    { source: \"emory\", target: \"gatech\", type: \"collaboration\", description: \"Joint Coulter Department of Biomedical Engineering\" },\n    { source: \"emory\", target: \"gsu\", type: \"collaboration\", description: \"NIH Antivirals Center (AC/DC)\" },\n    { source: \"emory\", target: \"morehouse\", type: \"collaboration\", description: \"Georgia CTSA Alliance\" },\n    { source: \"gatech\", target: \"morehouse\", type: \"collaboration\", description: \"Georgia CTSA Alliance\" },\n    { source: \"emory\", target: \"cdc\", type: \"collaboration\", description: \"Numerous research partnerships\" },\n    { source: \"emory\", target: \"choa\", type: \"collaboration\", description: \"Academic partner in pediatric research and clinical training\" },\n    { source: \"gatech\", target: \"choa\", type: \"collaboration\", description: \"Collaborates on pediatric medtech and translational research\" },\n    { source: \"emory\", target: \"emory_healthcare\", type: \"affiliation\", description: \"Clinical enterprise of Emory University; partner for translational and digital health research\" },\n    { source: \"emory_healthcare\", target: \"florence\", type: \"pilot\", description: \"Florence's eClinical tools validated in Emory Healthcare Innovation Hub pilot programs\" },\n    { source: \"switchboard_md\", target: \"emory_healthcare\", type: \"pilot\", description: \"Partnered with Emory Healthcare to implement and validate clinical operations and AI workflow tools\" },\n    { source: \"switchboard_md\", target: \"emory\", type: \"collaboration\", description: \"Founded by Emory-affiliated physicians and collaborates on applied AI and clinical operations research\" },\n    { source: \"catalyst\", target: \"wellstar\", type: \"affiliation\", description: \"Catalyst is the innovation and venture arm of Wellstar Health System\" },\n    { source: \"emory\", target: \"grady\", type: \"collaboration\", description: \"Emory partners with Grady for clinical care, research, and workforce development\" },\n    { source: \"morehouse\", target: \"grady\", type: \"collaboration\", description: \"Morehouse School of Medicine is a core academic partner at Grady\" },\n    { source: \"georgia_ctsa\", target: \"emory\", type: \"collaboration\", description: \"Core CTSA partner leading clinical trials infrastructure and translational science programs.\" },\n    { source: \"georgia_ctsa\", target: \"gatech\", type: \"collaboration\", description: \"Georgia Tech co-leads Georgia CTSA efforts in device development, data science, and commercialization support.\" },\n    { source: \"georgia_ctsa\", target: \"morehouse\", type: \"collaboration\", description: \"Partner in CTSA community engagement, clinical trial access, and translational research training.\" },\n    { source: \"georgia_ctsa\", target: \"gsu\", type: \"collaboration\", description: \"Contributes public health and behavioral science expertise to statewide CTSA programs.\" },\n    { source: \"georgia_ctsa\", target: \"grady\", type: \"infrastructure\", description: \"Operates clinical research units within Grady for translational and population health research.\" },\n    { source: \"georgia_ctsa\", target: \"choa\", type: \"infrastructure\", description: \"Supports pediatric clinical research infrastructure at CHOA sites.\" },\n\n    // --- VA Academic & Clinical Research Partnerships ---\n    { source: \"department_of_veterans_affairs\", target: \"emory\", type: \"collaboration\", description: \"Joint clinical research, many dual-appointed physician-scientists, major partner in translational medicine and clinical trials.\" },\n    { source: \"department_of_veterans_affairs\", target: \"morehouse\", type: \"collaboration\", description: \"NIH-funded clinical and translational science, joint community health studies as part of Georgia CTSA.\" },\n    { source: \"department_of_veterans_affairs\", target: \"gatech\", type: \"collaboration\", description: \"Device testing, digital health, and engineering partnerships on medtech pilots and translational projects.\" },\n    { source: \"department_of_veterans_affairs\", target: \"georgia_ctsa\", type: \"affiliation\", description: \"Formal affiliate of the Georgia Clinical & Translational Science Alliance (Georgia CTSA), Atlanta's NIH translational research consortium.\" },\n\n    { source: \"nucleate_atlanta\", target: \"gatech\", type: \"collaboration\", description: \"Nucleate Atlanta recruits founders and fellows from Georgia Tech graduate programs.\" },\n    { source: \"nucleate_atlanta\", target: \"emory\", type: \"collaboration\", description: \"Nucleate Atlanta partners with Emory students, postdocs, and faculty to launch biotech ventures.\" },\n    { source: \"nucleate_atlanta\", target: \"uga\", type: \"collaboration\", description: \"UGA students participate in Nucleate Atlanta's Activator and fellowship programs.\" },\n    { source: \"nucleate_atlanta\", target: \"gsu\", type: \"collaboration\", description: \"Georgia State students participate in Nucleate's regional cohort for Atlanta-based life sciences innovation.\" },\n\n    { source: \"gsu\", target: \"collabtech_gsu\", type: \"infrastructure\", description: \"CollabTech is Georgia State University's life sciences incubator providing lab space and core research facilities.\" },\n\n    { source: \"emory\", target: \"eidd\", type: \"infrastructure\", description: \"EIDD is a drug discovery and translational research center established and operated by Emory University.\" },\n    { source: \"science_square\", target: \"biospark_labs\", type: \"infrastructure\", description: \"BioSpark Labs is the shared wet‑lab and core facility node within the Science Square life sciences district in Atlanta.\" },\n    { source: \"portal\", target: \"biospark_labs\", type: \"infrastructure\", description: \"Portal Innovations Atlanta operates and supports BioSpark Labs within its Science Square facility, integrating venture support and lab infrastructure.\" },\n    { source: \"gatech\", target: \"biospark_labs\", type: \"infrastructure\", description: \"Georgia Tech helped establish BioSpark Labs at Science Square and its core facilities serve startups located there.\" },\n\n\n    { source: \"tag_digital_health\", target: \"georgia_bio\", type: \"affiliation\", description: \"TAG Digital Health Society collaborates statewide with Georgia Life Sciences (formerly Georgia Bio) on digital health ecosystem events and directories supporting biotech‐adjacent innovation.\" },\n    { source: \"emory\", target: \"adjust_center_emory\", type: \"infrastructure\", description: \"Emory University operates the ADJUST Center, housing translational diagnostics labs and equity‑focused assay development capabilities.\" },\n\n\n\n    { source: \"gatech\", target: \"piezo_therapeutics\", type: \"spinout\", description: \"Georgia Tech spinout focused on energy-based nucleic acid delivery technology.\" },\n    { source: \"gatech\", target: \"orthopreserve\", type: \"spinout\", description: \"Georgia Tech spinout founded in 2021 with medical device technology.\" },\n\n    // --- University Spinouts ---\n    { source: \"emory\", target: \"geovax\", type: \"spinout\", description: \"Technology developed at Emory\" },\n    { source: \"emory\", target: \"neurop\", type: \"spinout\", description: \"Founded by Emory faculty\" },\n    { source: \"emory\", target: \"altesa\", type: \"spinout\", description: \"Formed via Emory's DRIVE institute\" },\n    { source: \"emory\", target: \"braintrust\", type: \"spinout\", description: \"Founded by Emory faculty\" },\n    { source: \"emory\", target: \"topodx\", type: \"spinout\", description: \"Co-founded by Emory and GT researchers\" },\n    { source: \"emory\", target: \"cambium_oncology\", type: \"spinout\", description: \"Founded on IP licensed from Emory University; works closely with Winship Cancer Institute\" },\n    { source: \"gatech\", target: \"micron\", type: \"spinout\", description: \"Technology developed at Georgia Tech\" },\n    { source: \"gatech\", target: \"clearside\", type: \"spinout\", description: \"Based on GT/Emory microneedle tech\" },\n    { source: \"gatech\", target: \"moonlight\", type: \"spinout\", description: \"GT Capstone project spinout\" },\n    { source: \"gatech\", target: \"oxos\", type: \"spinout\", description: \"Formed via CREATE-X program\" },\n    { source: \"gatech\", target: \"sanguina\", type: \"spinout\", description: \"Co-founded by GT alumna from student research\" },\n    { source: \"sanguina\", target: \"emory\", type: \"spinout\", description: \"Georgia Tech / Emory research spinout—AnemoCheck platform developed with Wilbur Lam (Emory/GT) and clinically validated using Emory patient data.\" },\n    { source: \"gatech\", target: \"topodx\", type: \"spinout\", description: \"Developed out of Georgia Tech research\" },\n    { source: \"gatech\", target: \"metaclipse\", type: \"spinout\", description: \"Founded by Georgia Tech researchers; based on VLP platform technology developed at GT.\" },\n    { source: \"gatech\", target: \"andson_biotech\", type: \"spinout\", description: \"Georgia Tech spinout commercializing DynaChip™ microfluidic technology.\" },\n    { source: \"gatech\", target: \"axion_biosystems\", type: \"spinout\", description: \"Founded based on licensed technology from Georgia Tech NanoBioSensors Lab.\" },\n    { source: \"emory\", target: \"metaclipse\", type: \"collaboration\", description: \"Emory-affiliated advisors and founders contribute scientific expertise to VLP platform development.\" },\n    { source: \"avanos\", target: \"synaptrix\", type: \"spinout\", description: \"Spinout from Avanos Medical\" },\n\n    // --- VC Investments ---\n    { source: \"portal\", target: \"moonlight\", type: \"investment\", description: \"Co-led Series A for peanut allergy immunotherapy platform\" },\n    { source: \"portal\", target: \"synaptrix\", type: \"investment\", description: \"Portfolio company focused on post-surgical pain management\" },\n    { source: \"portal\", target: \"topodx\", type: \"investment\", description: \"Portfolio company advancing AI-driven AST diagnostics\" },\n    { source: \"armor_medical\", target: \"portal\", type: \"incubated_at\", description: \"Armor Medical is a tenant of Portal Innovations' BioSpark Labs at Science Square\" },\n    { source: \"eddf\", target: \"allonix\", type: \"investment\", description: \"EDDF portfolio investment in IBD therapeutics\" },\n    { source: \"eddf\", target: \"agrithera\", type: \"investment\", description: \"EDDF portfolio investment in cannabinoid neurotherapeutics\" },\n    { source: \"gra_fund\", target: \"micron\", type: \"investment\", description: \"Investor in Series A\" },\n\n    { source: \"catalyst\", target: \"armor_medical\", type: \"investment\", description: \"Catalyst by Wellstar invested in Armor Medical to support development of Maternal aRMOR wearable (Jun 2025).\" },\n    { source: \"gra_fund\", target: \"huxley_medical\", type: \"investment\", description: \"Portfolio investment in Huxley's SANSA patch platform for cardio-sleep diagnostics.\" },\n    { source: \"gra_fund\", target: \"biocircuit_technologies\", type: \"investment\", description: \"Early-stage investment in BioCircuit's Nerve Tape® nerve repair technology.\" },\n    { source: \"gra_fund\", target: \"geovax\", type: \"investment\", description: \"GeoVax is in the GRA Venture Fund portfolio\" },\n    { source: \"gra_fund\", target: \"clearside\", type: \"investment\", description: \"GRA Venture Fund held a 7.2% stake pre-IPO\" },\n    { source: \"gra_fund\", target: \"axion_biosystems\", type: \"investment\", description: \"GRA VF led Axion's early-stage round\" },\n    { source: \"gra\", target: \"huxley_medical\", type: \"funded_by\", description: \"Huxley Medical is listed in GRA's portfolio\" },\n\n    // --- Accelerator & Incubator Support ---\n    { source: \"atdc\", target: \"gatech\", type: \"affiliation\", description: \"Program of Georgia Tech\" },\n    { source: \"create_x\", target: \"gatech\", type: \"affiliation\", description: \"Program of Georgia Tech\" },\n    { source: \"atdc\", target: \"sanguina\", type: \"support\", description: \"Incubated at ATDC (alumni)\" },\n    { source: \"atdc\", target: \"strados_labs\", type: \"support\", description: \"Strados Labs is in ATDC's ATDC Accelerate portfolio of companies\" },\n    { source: \"create_x\", target: \"oxos\", type: \"support\", description: \"Incubated at CREATE-X (alumni)\" },\n    { source: \"biolocity\", target: \"sanguina\", type: \"support\", description: \"Received early grant funding\" },\n    { source: \"biolocity\", target: \"andson_biotech\", type: \"support\", description: \"Received translational funding and startup support from Biolocity.\" },\n\n    { source: \"emory\", target: \"ebfi\", type: \"affiliation\", description: \"Hosted and operated by Emory University\" },\n    { source: \"emory\", target: \"eddf\", type: \"affiliation\", description: \"Part of Emory Innovations, Inc.\" },\n\n    // --- DRIVE Relationships ---\n    { source: \"emory\", target: \"drive\", type: \"affiliation\", description: \"Emory-formed drug development accelerator for antiviral therapeutics\" },\n\n    { source: \"drive\", target: \"eddf\", type: \"origin\", description: \"Established EDDF using royalties from DRIVE-licensed drug molnupiravir (LAGEVRIO)\" },\n    { source: \"drive\", target: \"altesa\", type: \"spinout\", description: \"Antiviral spinout formed via DRIVE to develop Vapendavir and other respiratory virus therapies\" },\n    { source: \"drive\", target: \"agrithera\", type: \"funded_by\", description: \"Supported preclinical work on cannabinoid-based neurotherapeutics\" },\n\n    // --- Key Partnerships & Affiliations ---\n    { source: \"gatech\", target: \"science_square\", type: \"development\", description: \"Development partner (via GATV)\" },\n    { source: \"emory\", target: \"science_square\", type: \"housed_at\", description: \"Seven Emory labs relocating to Science Square (2025)\" },\n    { source: \"science_square\", target: \"portal\", type: \"tenant\", description: \"Anchor tenant\" },\n    { source: \"portal\", target: \"emory\", type: \"education_program\", description: \"Co-leads the Emory x Portal Innovation Certificate Program to train faculty and clinicians in biotech commercialization\" },\n    { source: \"portal\", target: \"jones_day\", type: \"education_program\", description: \"Co-hosts the Brewed & Briefed legal education series for life sciences founders at Portal's Atlanta office\" },\n\n    { source: \"portal\", target: \"radyus\", type: \"partnership\", description: \"Radyus Research is a Portal partner providing preclinical CRO services to early-stage life sciences ventures.\" },\n    { source: \"portal\", target: \"armor_medical\", type: \"member\", description: \"Armor Medical is a Portal Atlanta member company.\" },\n    { source: \"portal\", target: \"oridivus\", type: \"member\", description: \"Oridivus is a Portal Atlanta member company.\" },\n    { source: \"portal\", target: \"orthopreserve\", type: \"member\", description: \"OrthoPreserve is a Portal Atlanta member company.\" },\n    { source: \"portal\", target: \"lymphatech\", type: \"member\", description: \"LymphaTech is a Portal Atlanta member company.\" },\n    { source: \"portal\", target: \"ethos_medical\", type: \"member\", description: \"Ethos Medical is a Portal Atlanta member company.\" },\n    { source: \"portal\", target: \"oncospherix\", type: \"member\", description: \"OncoSpherix is a Portal Atlanta member company.\" },\n    { source: \"portal\", target: \"palate_therapeutics\", type: \"member\", description: \"Palate Therapeutics is a Portal Atlanta member company.\" },\n    { source: \"portal\", target: \"lybbie\", type: \"member\", description: \"Lybbie is a Portal Atlanta member company.\" },\n    { source: \"aruna_bio\", target: \"uga\", type: \"collaboration\", description: \"Aruna Bio is headquartered in Athens, GA and collaborates with University of Georgia on neural stem cell research and drug development.\" },\n    { source: \"accuitis\", target: \"emory\", type: \"spinout\", description: \"Accuitis Pharmaceuticals key technology was discovered by Emory University.\" },\n    { source: \"accuitis\", target: \"gra\", type: \"program\", description: \"Accuitis is a participant in the Georgia Research Alliance Venture Lab program.\" },\n    { source: \"diasyst\", target: \"emory\", type: \"collaboration\", description: \"Diasyst is backed by decades of research at Emory University and the VA.\" },\n    { source: \"diasyst\", target: \"gra\", type: \"funding\", description: \"Diasyst received GRA funding in 2019.\" },\n    { source: \"earlitec\", target: \"emory\", type: \"collaboration\", description: \"EarliTec Diagnostics collaborates with Emory University on autism research and clinical validation studies.\" },\n    { source: \"kodikaz\", target: \"emory\", type: \"collaboration\", description: \"Kodikaz Therapeutics collaborates with Emory University on gene therapy research. Co-Founder Dr. Leon Bernal-Mizrachi is Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine.\" },\n    { source: \"nyra_medical\", target: \"emory\", type: \"spinout\", description: \"Nyra Medical was founded in 2021 based on intellectual property developed at Emory University by Dr. Murali Padala. The company licensed its core CARLEN technology from Emory University.\" },\n    { source: \"gra_fund\", target: \"accuitis\", type: \"investment\", description: \"Accuitis is a GRA Venture Fund portfolio company developing dermatology drugs for rosacea.\" },\n    { source: \"gra_fund\", target: \"aruna_bio\", type: \"investment\", description: \"ArunA Biomedical is a GRA Venture Fund portfolio company developing exosome therapeutics for neurodegeneration.\" },\n    { source: \"gra_fund\", target: \"diasyst\", type: \"investment\", description: \"Diasyst is a GRA Venture Fund portfolio company developing chronic disease management tools.\" },\n    { source: \"gra_fund\", target: \"earlitec\", type: \"investment\", description: \"EarliTec Diagnostics is a GRA Venture Fund portfolio company developing early diagnosis tools for autism and developmental disorders.\" },\n    { source: \"gra_fund\", target: \"kodikaz\", type: \"investment\", description: \"Kodikaz is a GRA Venture Fund portfolio company developing gene therapies for cancer.\" },\n    { source: \"gra_fund\", target: \"nyra_medical\", type: \"investment\", description: \"Nyra Medical is a GRA Venture Fund portfolio company developing transcatheter mitral valve repair technology.\" },\n    { source: \"gra_fund\", target: \"sanguina\", type: \"investment\", description: \"Sanguina is a GRA Venture Fund portfolio company developing hemoglobin testing via smartphone (AnemoCheck).\" },\n\n    { source: \"catalyst\", target: \"atdc\", type: \"partnership\", description: \"Formal partnership for HealthTech pipeline\" },\n\n    { source: \"biolocity\", target: \"emory\", type: \"collaboration\", description: \"Joint program with Emory\" },\n    { source: \"biolocity\", target: \"gatech\", type: \"collaboration\", description: \"Joint program with Georgia Tech\" },\n    { source: \"biolocity\", target: \"lab2launch\", type: \"support\", description: \"Biolocity subsidizes and guides startups in Lab2Launch, includes programmatic support and consultation.\" },\n    { source: \"emory\", target: \"lab2launch\", type: \"infrastructure\", description: \"Lab2Launch located onsite at Emory's HSRB II Innovation Floor; supports Emory-affiliated innovators.\" },\n    { source: \"emory_ott\", target: \"emory\", type: \"affiliation\", description: \"Office of Technology Transfer is Emory's formal commercialization & IP licensing arm.\" },\n    { source: \"emory_ott\", target: \"biolocity\", type: \"collaboration\", description: \"OTT collaborates with Biolocity to connect researchers to commercialization funding and support programs.\" },\n    \n    // --- Quadrant-i Relationships ---\n    { source: \"gatech\", target: \"quadrant_i\", type: \"affiliation\", description: \"Quadrant-i is a Georgia Tech commercialization and venture creation unit accelerating research translation into startups.\" },\n    { source: \"quadrant_i\", target: \"biolocity\", type: \"collaboration\", description: \"Quadrant-i Principals advise Biolocity projects and help connect funded teams to investors and partners.\" },\n    { source: \"quadrant_i\", target: \"emory\", type: \"collaboration\", description: \"Collaborates on Emory-affiliated Biolocity projects such as Infinite Loupe and OnCuRNA.\" },\n    { source: \"quadrant_i\", target: \"exvade_bioscience\", type: \"support\", description: \"Supported commercialization of continuous glioblastoma biopsy device developed at Georgia Tech.\" },\n    { source: \"quadrant_i\", target: \"oncurna\", type: \"support\", description: \"Assisted Georgia Tech researchers in forming OnCuRNA, focused on solid tumor RNAi therapeutics.\" },\n    { source: \"biolocity\", target: \"oncurna\", type: \"support\", description: \"Biolocity-supported startup selected in 2025-26 cohort for ovarian cancer drug delivery platform, receiving mentorship and non-dilutive funding.\" },\n    { source: \"biolocity\", target: \"cambium_oncology\", type: \"support\", description: \"Biolocity portfolio company developing precision oncology therapeutics based on Emory research.\" },\n    { source: \"biolocity\", target: \"metaclipse\", type: \"support\", description: \"Biolocity portfolio company developing VLP vaccine platform technology from Georgia Tech research.\" },\n    { source: \"biolocity\", target: \"dr_noze_best\", type: \"support\", description: \"Biolocity portfolio company developing pediatric health and wellness solutions including the NozeBot nasal aspirator.\" },\n    { source: \"biolocity\", target: \"codoxo\", type: \"support\", description: \"Biolocity portfolio company developing AI-powered healthcare payment integrity and fraud detection solutions.\" },\n    { source: \"atdc\", target: \"dr_noze_best\", type: \"funding\", description: \"ATDC-funded company developing pediatric health and wellness solutions including the NozeBot nasal aspirator.\" },\n    \n    // --- VentureLab Relationships ---\n    { source: \"gatech\", target: \"venturelab\", type: \"affiliation\", description: \"VentureLab is Georgia Tech's startup launch and commercialization support hub.\" },\n    { source: \"venturelab\", target: \"quadrant_i\", type: \"collaboration\", description: \"VentureLab works upstream of Quadrant-i to identify and nurture promising tech transfer opportunities.\" },\n    { source: \"venturelab\", target: \"biolocity\", type: \"collaboration\", description: \"Refers high-potential GT teams to Biolocity for translational medtech support and funding.\" },\n    { source: \"gatech\", target: \"cambium_oncology\", type: \"research_collaboration\", description: \"Georgia Tech bioengineering and drug manufacturing support\" },\n    // --- VA Company & Startup Connections ---\n    { source: \"department_of_veterans_affairs\", target: \"oxos\", type: \"pilot\", description: \"Pilot program with OXOS Medical for handheld X-ray devices in VA hospitals.\" },\n    { source: \"department_of_veterans_affairs\", target: \"diasyst\", type: \"collaboration\", description: \"Clinical implementation and validation of diabetes management software, building on joint Emory/VA research.\" },\n    { source: \"department_of_veterans_affairs\", target: \"tempus\", type: \"research\", description: \"Tempus (via acquired AKESOgen) conducted genomics work for VA's Million Veteran Program.\" },\n    { source: \"oxos\", target: \"department_of_veterans_affairs\", type: \"partnership\", description: \"Pilot program partnership\" },\n    { source: \"micron\", target: \"cdc\", type: \"partnership\", description: \"Research and clinical trial collaboration\" },\n    { source: \"iqvia_atlanta\", target: \"cdc\", type: \"partnership\", description: \"Real-world data partnership\" },\n\n\n    // --- Service Provider Relationships ---\n\n\n    { source: \"biotechexec\", target: \"biolocity\", type: \"service\", description: \"Mentorship and strategic consulting\" },\n    { source: \"mng_labs\", target: \"emory\", type: \"service\", description: \"Neurogenetic testing services vendor\" },\n    { source: \"radyus\", target: \"cambium_oncology\", type: \"service\", description: \"Longtime CRO and strategic consulting partner\" },\n    { source: \"woven_health_collective\", target: \"emory_healthcare\", type: \"collaboration\", description: \"Strategic partner to the Emory Healthcare Innovation Hub, enabling clinical UX testing and healthcare product validation\" },\n\n    { source: \"vizzia\", target: \"choa\", type: \"service\", description: \"Selected by CHOA to deploy RTLS and asset tracking for Arthur M. Blank Hospital (2025).\" },\n    { source: \"vizzia\", target: \"piedmont_healthcare\", type: \"service\", description: \"Deployed RTLS platform at Marcus Tower (16-story, $603M hospital project).\" },\n    { source: \"vizzia\", target: \"grady\", type: \"service\", description: \"Implemented RTLS and environmental monitoring system at Correll Pavilion (10-story surgical center).\" },\n    { source: \"rimidi\", target: \"emory_healthcare\", type: \"pilot\", description: \"Partnered with Emory Healthcare to deploy digital treatment apps supporting personalized care.\" },\n\n    // --- Broader Ecosystem Connections ---\n    { source: \"gra\", target: \"emory\", type: \"funding\", description: \"Supports Emory through endowed chairs, translational research, and startup formation funding.\" },\n    { source: \"gra\", target: \"gatech\", type: \"funding\", description: \"Funds Georgia Tech research translation and startup formation; GRA Scholars often hosted here.\" },\n    { source: \"gra\", target: \"uga\", type: \"funding\", description: \"Supports innovation and entrepreneurship across UGA's pharmacy, agbio, and veterinary programs.\" },\n    { source: \"gra\", target: \"morehouse\", type: \"funding\", description: \"Partners in Georgia CTSA and supports research infrastructure at Morehouse.\" },\n    { source: \"gra\", target: \"gsu\", type: \"funding\", description: \"Supports infectious disease and neuro research; GRA Scholars hosted at Georgia State.\" },\n\n    { source: \"gra\", target: \"gra_fund\", type: \"affiliation\", description: \"GRA Venture Fund is the investment arm of the Georgia Research Alliance, supporting university-affiliated startups with seed-stage capital.\" },\n    { source: \"gra\", target: \"micron\", type: \"funding\", description: \"Provided translational research and matching capital support.\" },\n    { source: \"gra\", target: \"clearside\", type: \"funding\", description: \"Clearside's founding research supported through GRA-backed technology and translational grants.\" },\n    { source: \"gra\", target: \"altesa\", type: \"funding\", description: \"GRA supported Emory DRIVE institute underlying Altesa's antiviral research.\" },\n    { source: \"gra\", target: \"allonix\", type: \"funding\", description: \"Backed Emory IP and early preclinical studies through GRA-sponsored programs.\" },\n    { source: \"gra\", target: \"cambium_oncology\", type: \"funding\", description: \"Supported foundational cancer research programs at Emory that seeded Cambium.\" },\n    { source: \"gra\", target: \"andson_biotech\", type: \"funding\", description: \"Received early translational support from Georgia Research Alliance.\" },\n    { source: \"gra\", target: \"axion_biosystems\", type: \"funding\", description: \"Received financial backing via Georgia Research Alliance / GRA Venture Fund.\" },\n\n    { source: \"emory_biotech_consulting_club\", target: \"emory\", type: \"affiliation\", description: \"EBCC is a student-led commercialization and consulting program founded at Emory University under the Innovate@Emory initiative.\" },\n    { source: \"emory_biotech_consulting_club\", target: \"emory_ott\", type: \"collaboration\", description: \"Partners with Emory OTT to support technology assessments and connect student teams to Emory-affiliated startups.\" },\n    { source: \"emory_biotech_consulting_club\", target: \"biolocity\", type: \"collaboration\", description: \"Collaborates with Biolocity to provide commercialization strategy support for early-stage medtech projects.\" },\n    { source: \"emory_biotech_consulting_club\", target: \"gra\", type: \"collaboration\", description: \"Engages with Georgia Research Alliance through university commercialization programs and startup diligence efforts.\" },\n    \n    // --- EBCC Client Relationships ---\n    { source: \"emory_biotech_consulting_club\", target: \"switchboard_md\", type: \"service\", description: \"EBCC Spring 2024 client - provided commercialization strategy for AI-based triage platform\" },\n    { source: \"emory_biotech_consulting_club\", target: \"emtherapro\", type: \"service\", description: \"EBCC Fall 2023 client - provided commercialization strategy for proteomics platform\" },\n    { source: \"emory_biotech_consulting_club\", target: \"fibronox\", type: \"service\", description: \"EBCC Spring 2022 client - provided commercialization strategy for fibrotic disease therapeutics\" },\n    { source: \"emory_biotech_consulting_club\", target: \"metaclipse\", type: \"service\", description: \"EBCC Spring 2020 client - provided commercialization strategy for cancer immunotherapy platform\" },\n    { source: \"emory_biotech_consulting_club\", target: \"cambium_oncology\", type: \"service\", description: \"EBCC Fall 2019 client - provided commercialization strategy for immuno-oncology therapeutics\" },\n    { source: \"emory_biotech_consulting_club\", target: \"oncospherix\", type: \"service\", description: \"EBCC Spring 2019 client - provided commercialization strategy for oncology drug development\" },\n    { source: \"emory_biotech_consulting_club\", target: \"nyra_medical\", type: \"service\", description: \"EBCC Spring 2020 client - provided commercialization strategy for cardiac device technology\" },\n    { source: \"eddf\", target: \"emory\", type: \"funding\", description: \"Direct laboratory investment in CFTR-targeted therapies via Sorscher Lab\" },\n\n    // --- CollabTech Tenant Relationships ---\n    { source: \"andson_biotech\", target: \"collabtech_gsu\", type: \"tenant\", description: \"Andson Biotech is a current tenant at CollabTech incubator, developing DynaChip™ microfluidic technology.\" },\n    { source: \"palate_therapeutics\", target: \"collabtech_gsu\", type: \"tenant\", description: \"Palate Therapeutics is a current tenant at CollabTech incubator, developing oral oligonucleotide therapy for metabolic diseases.\" },\n    { source: \"piezo_therapeutics\", target: \"collabtech_gsu\", type: \"tenant\", description: \"Piezo Therapeutics is a current tenant at CollabTech incubator, developing energy-based nucleic acid delivery technology.\" },\n    { source: \"neurop\", target: \"collabtech_gsu\", type: \"graduate\", description: \"NeurOp is a CollabTech graduate, having incubated at Georgia State University's biotech incubator before advancing to clinical-stage CNS drug development.\" },\n\n    // --- Emtherapro and Arc Proteomics Connections ---\n    { source: \"emtherapro\", target: \"emory\", type: \"spinout\", description: \"Emory spinout transforming diagnosis and treatment of neurodegenerative diseases through pioneering science, data and insights.\" },\n    { source: \"emtherapro\", target: \"jones_day\", type: \"service\", description: \"Uses Jones Day for legal counsel.\" },\n    { source: \"arc_proteomics\", target: \"emory\", type: \"spinout\", description: \"Emory spinout located in Decatur, GA specializing in proteome-wide assays for biomarker discovery.\" },\n    { source: \"arc_proteomics\", target: \"jones_day\", type: \"service\", description: \"Uses Jones Day for legal counsel.\" },\n\n    // --- SynthBiome Connections ---\n    { source: \"synthbiome\", target: \"gatech\", type: \"spinout\", description: \"SynthBiome founded by Georgia Tech faculty Marvin Whiteley, developing synthetic environments for drug development and treatment selection. Whiteley's 10-year research program on bacterial behavior in human environments led to the creation of synthetic media that accurately replicate human infection conditions.\" },\n    { source: \"synthbiome\", target: \"biospark_labs\", type: \"tenant\", description: \"SynthBiome is one of five startups based at BioSpark Labs, where it develops synthetic environments to accelerate antibiotic drug discovery and overcome the challenge of translating lab discoveries to clinical success.\" },\n    { source: \"orthopreserve\", target: \"biospark_labs\", type: \"tenant\", description: \"OrthoPreserve is based at BioSpark Labs, a life sciences incubator space in Georgia Tech's Science Square district.\" },\n\n    // --- Tether Therapeutics Connections ---\n    { source: \"tether_therapeutics\", target: \"gatech\", type: \"spinout\", description: \"Tether Therapeutics technology based on novel chemistry developed at Georgia Tech, developing biodegradable polymeric nanoparticles for aerosol gene delivery to treat respiratory diseases.\" },\n    { source: \"tether_therapeutics\", target: \"emory\", type: \"spinout\", description: \"Tether Therapeutics technology based on novel chemistry developed at Emory University, creating next-generation delivery solutions for mRNA therapeutics targeting respiratory diseases.\" },\n\n    // --- YoungHeartValve Connections ---\n    { source: \"youngheartvalve\", target: \"emory\", type: \"collaboration\", description: \"YoungHeartValve collaborates with Emory-affiliated cardiovascular surgeons including Vinod Thourani, MD of Piedmont Heart Institute, for clinical validation of next-generation heart valve technology.\" },\n\n    // --- Ora Lee Foundation Connections ---\n    // Note: No verified connections found yet - will add when confirmed relationships are established\n\n    // --- Odylia Therapeutics Connections ---\n    // Note: No verified connections found yet - will add when confirmed relationships are established\n\n    // --- Missing GRA Portfolio Connections ---\n    { source: \"gra_fund\", target: \"nutrivert\", type: \"investment\", description: \"GRA Venture Fund portfolio company developing alternatives to veterinary livestock antibiotics market.\" },\n\n    // --- Veranex Connections ---\n    { source: \"veranex\", target: \"science_square\", type: \"tenant\", description: \"Veranex operates T3 Labs facility in Science Square, Atlanta's growing life sciences hub.\" },\n    { source: \"veranex\", target: \"cdc\", type: \"collaboration\", description: \"Strategic community relationship with CDC for preclinical research and public health initiatives.\" },\n    { source: \"veranex\", target: \"emory\", type: \"collaboration\", description: \"Strategic community relationship with Emory University for preclinical research and medical device development.\" },\n    { source: \"veranex\", target: \"gatech\", type: \"collaboration\", description: \"Strategic community relationship with Georgia Tech for preclinical research and medical device development.\" },\n    { source: \"youngheartvalve\", target: \"veranex\", type: \"service\", description: \"YoungHeartValve located at T3 Labs facility (now part of Veranex) for preclinical testing and development support.\" },\n\n    // --- OZ-Link Technologies Connections ---\n    { source: \"oz_link_technologies\", target: \"gatech\", type: \"collaboration\", description: \"OZ-Link Technologies collaborates with Georgia Tech researchers on polymer chemistry and bioconjugation technologies for controlled release therapeutics.\" },\n\n    // --- LymphaTech Connections ---\n    { source: \"lymphatech\", target: \"gatech\", type: \"spinout\", description: \"LymphaTech founded by Georgia Tech faculty J. Brandon Dixon, developing innovative 3D measurement solutions for clinical care using proprietary algorithms for accurate human geometry measurement.\" },\n    { source: \"lymphatech\", target: \"gra\", type: \"funding\", description: \"LymphaTech received seed funding from Georgia Research Alliance in 2015 to support development of digital measuring platform for healthcare applications.\" },\n\n    // --- Jackson Medical Connections ---\n    { source: \"jackson_medical\", target: \"emory_healthcare\", type: \"partnership\", description: \"Jackson Medical's GloShield™ surgical safety device is used in healthcare systems including Emory Healthcare to prevent fiber-optic cable fires and burns in operating rooms.\" },\n\n    // --- Ethos Medical Connections ---\n    { source: \"ethos_medical\", target: \"portal\", type: \"tenant\", description: \"Ethos Medical is a member of Portal Innovations at Science Square, receiving support for development of the Iris needle guidance system for safer percutaneous access.\" },\n    { source: \"ethos_medical\", target: \"gatech\", type: \"collaboration\", description: \"Ethos Medical collaborates with Georgia Tech researchers on ultrasound-guided needle guidance technology and real-time image guidance systems.\" },\n\n    // --- Rowen Foundation Partner Connections ---\n    { source: \"rowen\", target: \"uga\", type: \"partnership\", description: \"University of Georgia is a key academic partner in Rowen Foundation's 2,000-acre knowledge community focused on biotech, agriculture, and environmental tech.\" },\n    { source: \"rowen\", target: \"emory\", type: \"partnership\", description: \"Emory University collaborates with Rowen Foundation on biotech and environmental research initiatives in the 2,000-acre innovation district.\" },\n    { source: \"rowen\", target: \"gatech\", type: \"partnership\", description: \"Georgia Tech partners with Rowen Foundation on technology development and commercialization initiatives in the knowledge community.\" },\n    { source: \"rowen\", target: \"georgia_bio\", type: \"partnership\", description: \"Georgia Life Sciences (formerly Georgia Bio) collaborates with Rowen Foundation on statewide biotech ecosystem development and industry partnerships.\" },\n\n    // --- VA Broader Ecosystem Connection ---\n    { source: \"department_of_veterans_affairs\", target: \"georgia_bio\", type: \"affiliation\", description: \"Ecosystem stakeholder and clinical/policy partner for workforce and translational initiatives.\" },\n\n    { source: \"gra_fund\", target: \"earlitec\", type: \"investment\", description: \"EarliTec Diagnostics is a GRA Venture Fund portfolio company developing early diagnosis tools for autism and developmental disorders.\" },\n\n    // --- Keiretsu Forum South-East Connections ---\n    { source: \"keiretsu_southeast\", target: \"atdc\", type: \"partnership\", description: \"Co-hosts Southeast Investor Conference (July 2025) with ATDC and Angel Capital Association, featuring startup showcases and angel investment programming for accredited investors.\" },\n    { source: \"keiretsu_southeast\", target: \"gatech\", type: \"partnership\", description: \"Partners with ATDC to host Southeast Investor Conference (July 2025), featuring startup showcases and angel investment programming.\" },\n\n    // --- Accelerator & Incubator Support ---\n  ]\n};\n\n// Node type mappings for filtering (Updated & Expanded for consistency)\nexport const nodeTypeMap = {\n    company: 'Company',\n    public_company: 'Company',\n    startup: 'Startup',\n    university: 'Academia & Research',\n    research_institution: 'Academia & Research',\n    health_system: 'Provider & Health System',\n    vc: 'Investor',\n    accelerator: 'Accelerator & Incubator',\n    incubator: 'Accelerator & Incubator',\n    facility: 'Accelerator & Incubator',\n    government: 'Government & Trade Org',\n    trade: 'Government & Trade Org',\n    development: 'Government & Trade Org',\n    serviceProvider: 'Service Provider',\n    cro: 'Service Provider',\n    law_firm: 'Service Provider',\n    consulting: 'Service Provider',\n    community: 'Community Builder',\n};\n\n// Color scheme for different node types (Updated for better visual distinction)\nexport const nodeColors = {\n    'Academia & Research': '#0033A0', // Dark Blue\n    'Company': '#0D6A42', // Green\n    'Investor': '#F2A900', // Gold\n    'Accelerator & Incubator': '#A43533', // Red\n    'Government & Trade Org': '#5A2D81', // Purple\n    'Service Provider': '#545454', // Gray\n    'Startup': '#00AEEF', // Light Blue\n    'Provider & Health System': '#7C9A7A', // Sage\n    'Community Builder': '#E67300', // Orange\n};\n\nexport default atlantaBiotechEcosystem;"],"names":["atlantaBiotechEcosystem","nodes","id","name","type","size","description","website","keyPersonnel","recentNews","links","source","target","nodeTypeMap","company","public_company","startup","university","research_institution","health_system","vc","accelerator","incubator","facility","government","trade","development","serviceProvider","cro","law_firm","consulting","community","nodeColors"],"sourceRoot":""}